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Summary 
The DEG/ENaC ion channel family comprises a group of phylogenetically related ion 
channels found in almost all multicellullar animals (metazoa). Common characteristics of 
DEG/ENaCs are their selectivity for Na+ and their sensitivity for the inhibitor amiloride. 
Besides these shared features, the individual DEG/ENaCs display a huge diversity with 
regard to their expression pattern, stimulus of activation and their physiological function. For 
example, ASICs are proton-gated channels implied in the perception of pain while ENaCs 
are constitutively active and facilitate sodium reabsorption across epithelia and FaNaC is 
the first identified ion channel directly gated by neuropeptides. To obtain a better 
understanding of the basic properties of this heterogeneous group of ion channels, our 
group has cloned novel DEG/ENaC subunits from the freshwater polyp Hydra 
magnipapillata. Hydra belongs to the phylum Cnidaria, which is considered as the most 
ancient phylum in which a nervous system has evolved. Therefore, the characterisation of 
DEG/ENaC channels from Hydra will help to identify principal and basic properties, which 
are shared by all DEG/ENaC members. So far, our group has cloned four DEG/ENaC 
subunits from Hydra, which were named HyNaC1-4. It was already shown that coinjection 
of the subunits HyNaC2 and -3 leads to expression of a functional ion channel in Xenopus 
oocytes that is directly gated by endogenous neuropeptides from Hydra, the 
HydraRFamides I and II. To date, HyNaCs and related FMRFamide-gated sodium channels 
(FaNaCs) are the only known peptide-gated ion channels. 
In this work HyNaC5, a novel DEG/ENaC subunit from Hydra, was investigated. When 
HyNaC5 was coexpressed together with HyNaC2 and -3, the apparent affinity for the 
HydraRFamides I and II was increased ≈100-fold. In addition, HyNaC2/3/5 exhibited an 
increased selectivity for Na+ and was blocked more potently by the inhibitor amiloride than 
HyNaC2/3. In summary, the results confirm that the subunits HyNaC2, -3, and -5 together 
form a heterotrimeric, peptide-gated ion channel. Moreover, the increased current 
amplitudes, the increased apparent affinity for the HydraRFamides and the enhanced 
sensitivity for the inhibitor amiloride collectively suggest that the ion channel consisting of 
HyNaC2/3/5 and not HyNaC2/3 is the physiologically relevant channel in Hydra. 
In the second part of this thesis it was shown that the channel formed by HyNaC2/3/5 is 
also highly permeably for Ca2+. This finding is surprising, as all known DEG/ENaCs are Ca2+ 
impermeable or conduct Ca2+ only to a minor extend. Indeed, selectivity for Na+ is a 
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common and name giving feature of DEG/ENaCs. We estimated a relative Ca2+ 
permeability (PCa/PNa) of ≈3.8, which places HyNaC2/3/5 into the group of highly Ca2+ 
conductive channels. In Xenopus oocytes, the influx of Ca2+ through HyNaCs was directly 
visible by secondary activation of endogenously expressed calcium activated chloride 
channels (CaCCs). The block of CaCCs revealed the simple, step-like and non-
desensitizising current characteristic of HyNaC2/3/5. Moreover, it was shown that Ca2+ also 
blocks HyNaC2/3/5. The block was voltage-dependent and increased at more positive 
potentials. Furthermore, a conserved aspartate residue situated at the outer entrance of the 
ion pore that is essential for both, the high Ca2+ permeability and the Ca2+ block of 
HyNaC2/3/5 was identified. Substitution of this residue led to a strong reduction of Ca2+ 
permeability and reduced voltage dependent Ca2+ block. By an in situ hybridisation assay, 
the expression pattern of hynac2, -3, and -5 was localized at the base of the tentacles in 
Hydra. The expression overlapped with the previously reported expression of the 
HydraRFamides I and II. We therefore speculate that HyNaCs - possibly mediated by their 
permeability for Ca2+ - might play a role in the coordinated movement of the tentacles during 
feeding in Hydra. Indeed, we could show that application of amiloride, a universal inhibitor 
of DEG/ENaCs, delays the glutathione induced feeding reaction in Hydra. 
In addition, the identification of a novel DEG/ENaC with high permeability for Ca2+ from 
Hydra suggest that selectivity for Na+ was not shared by the common ancestor of all 
DEG/ENaCs and arose later in evolution. 
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Zusammenfassung 
Die DEG/ENaC Ionenkanalfamilie umfasst eine Gruppe phylogenetisch verwandter 
Ionenkanäle, die in nahezu allen vielzelligen Tieren (Metazoen) zu finden sind. Ein 
charakteristisches Merkmal aller DEG/ENaC Kanäle ist ihre Selektivität für Natrium sowie 
die Sensitivität gegenüber dem Inhibitor Amilorid. Neben diesen Gemeinsamkeiten bilden 
die einzelnen Vertreter der DEG/ENaC Familie hinsichtlich ihrer Expressionsmuster, ihrer 
Aktivierungsmechanismen und ihrer physiologischen Funktion eine sehr heterogene 
Gruppe. So sind beispielsweise die durch Protonen aktivierten ASICs an der 
Schmerzwahrnehmung beteiligt; ENaC vermittelt als konstitutiv geöffneter Kanal die 
Natriumresorption über Epithelien und FaNaC ist der erste beschriebene Ionenkanal, der 
durch endogene Neuropeptide aktiviert wird. Um ein besseres Verständnis grundlegender 
Eigenschaften dieser heterogenen Kanalfamilie zu erhalten und ursprüngliche 
Funktionsweisen der Kanalfamilie  zu erforschen wurden durch unsere Arbeitsgruppe neue 
DEG/ENaC Untereinheiten aus dem Süßwasserpolypen Hydra magnipapillata kloniert. 
Hydra gehört zum Phylum Cnidaria, dem evolutionär ältesten Tierstamm in dem sich ein 
Nervensystem entwickelte. Die Beschreibung der Eigenschaften von DEG/ENaC Kanälen 
aus Hydra kann somit wichtige Impulse für die Erforschung grundlegender Mechanismen 
aller DEG/ENaC Kanäle liefern. 
Bisher wurden von unserer Gruppe vier neue DEG/ENaC Untereinheiten aus Hydra kloniert 
und HyNaC1-4 genannt. In einer früheren Arbeit konnte bereits gezeigt werden, dass die 
Untereinheiten HyNaC2 und -3 einen funktionellen Ionenkanal bilden, der durch endogene 
Neuropeptide aus Hydra, die HydraRFamide I und II, direkt aktiviert wird. Bis heute sind 
HyNaCs und der verwandte FMRFamide-gated sodium channel (FaNaC) die einzigen 
bekannten peptidaktivierten Ionenkanäle. 
In dieser Arbeit wurde HyNaC5, eine weitere DEG/ENaC Untereinheit aus Hydra, 
untersucht. Wird HyNaC5 zusammen mit HyNaC2 und -3 exprimiert, so erhöhte sich die 
apparente Affinität für die HydraRFamide I und II etwa 100-fach. Zudem zeigte HyNaC2/3/5 
im Vergleich zu HyNaC2/3 eine erhöhte Selektivität für Natrium und war stärker durch den 
Inhibitor Amilorid blockierbar. Zusammenfassend belegen diese Ergebnisse, dass die 
Untereinheiten HyNaC2, -3 und -5 gemeinsam einen heterotrimeren, peptidaktivierten 
Ionenkanal bilden. Die nach Koexpression von HyNaC5 vergrößerten Stromamplituden, die 
erhöhte Affinität für die HydraRFamide sowie die größere Sensitivität für Amilorid deuten 
zudem darauf hin, dass es sich bei HyNaC2/3/5 und nicht bei HyNaC2/3 um die in Hydra 
physiologisch relevante Kanalform handelt.  
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In zweiten Teil dieser Arbeit konnte gezeigt werden, dass HyNaC2/3/5 stark permeabel für 
Kalzium ist. Dieses Ergebnis ist überraschend, da alle bekannten DEG/ENaCs keine oder 
nur geringe Leitfähigkeit für Kalzium besitzen und Natriumselektivität ein vereinendes und 
namensgebendes Merkmal der DEG/ENaC Ionenkanalfamilie ist. Die ermittelte 
Kalziumpermeabilität (PCa/PNa ≈3.8) zeigt, dass HyNaC2/3/5 in die Gruppe stark 
kalziumpermeabler Ionenkanäle einzuordnen ist. In Xenopus Oozyten führte der 
Kalziuminflux durch HyNaC2/3/5 zur Aktivierung endogen exprimierter, kalziumabhängiger 
Chloridkanäle (CaCCs), die den Kalziumeinstrom direkt anzeigten. Durch den Block der 
CaCCs konnte die einfache, treppenförmige und nicht desensitisierende 
Stromcharakteristik von HyNaC2/3/5 aufgeklärt werden. Zudem konnte gezeigt werden, 
dass HyNaC2/3/5 zusätzlich durch Kalzium blockiert wird. Der Block war 
spannungsabhängig und verstärkte sich bei positiven Potentialen. Es zeigte sich, dass ein 
konserviertes Aspartat kurz vor dem extrazellulären Poreneingang sowohl für die 
Kalziumleitfähigkeit als auch für den Kalziumblock von HyNaC2/3/5 essentiell ist. Der 
Austausch dieser Aminosäure führte zu stark verminderter Kalziumleitfähigkeit und einer 
Verringerung des spannungsabhängigen Kalziumblocks. Durch eine in situ Hybridisierung 
wurde die Expression von hynac2, -3 und -5 an der Tentakelbasis von Hydra nachgewiesen 
werden. Dieses Expressionsmuster überlappt mit der Expression der HydraRFamide I und 
II. Daher könnten HyNaCs, eventuell vermittelt durch deren Kalziumleitfähigkeit, eine 
wichtige Funktion bei der Koordination der Tentakelbewegung während der 
Nahrungsaufnahme spielen. Tatsächlich konnten wir zeigen, dass die durch Glutathion 
induzierte „feeding reaction“ in Hydra durch Applikation des DEG/ENaC Inhibitors Amilorid 
verlangsamt wird. Die Entdeckung eines DEG/ENaC Kanals mit hoher Kalziumleitfähigkeit 
aus Hydra weist zudem darauf hin, dass Natriumselektivität bei dem gemeinsamen 
Vorläufer der Kanalfamilie möglicherweise noch nicht ausgeprägt war, sondern sich in der 
Evolution später entwickelte. 
 
Introduction 
5 
I. Introduction 
1.1. Introduction to the DEG/ENaC ion channel 
superfamily 
1.1.1 Discovery and classification 
The DEG/ENaC ion channel superfamily forms a group of nonvoltage gated, Na+-selective 
and amiloride-sensitive cation channels expressed in multicellular organisms throughout the 
animal kingdom. The channel family is named after their founding members, the degenerins 
(DEG) from C. elegans and the mammalian epithelial sodium channel (ENaC) (Deval et al., 
2003). The DEG/ENaC family is defined by the sequence homology of its members and a 
phylogenetic tree of the individual family members is shown in Fig. 1. Despite their 
relationship, the individual family members - that are now shortly introduced- display a large 
diversity with regard to their physiological function, their expression pattern and their 
stimulus of activation:  
The founding members from Caenorhabditis elegans, the degenerins deg-1 and mec-4 
were identified in a genetic screen for touch-insensitive mutants (Chalfie and Au, 1989; 
Driscoll and Chalfie, 1991). They are, together with several other degenerins, responsible 
for touch sensation. Only few years later, the α, β and γ subunits of the rat epithelial sodium 
channel (ENaC) were cloned in 1993 and 1994 from epithelial colon cells and were 
functionally expressed in Xenopus oocytes (Canessa et al., 1993; 1994). The structural 
homology to the degenerins led to the classification of both channels to a common family 
(Kellenberger and Schild, 2002). ENaC is a constitutivley open channel involved in sodium 
reabsorption across epithelia (Firsov et al., 1996).  
The first ligand-gated DEG/ENaC and the first identified ion channel that is directly gated by 
a neuropeptide was cloned in 1995 from the snail Helix aspersa and named FaNaC 
(FMRFamide-gated sodium channel) (Lingueglia et al., 1995). The FMRFamide (Phe-Met-
Arg-Phe) or related mammalian peptides are implied in various physiological functions 
ranging from control of heart rate in molluscs to pain modulation in mammals (Perry et al., 
2001; Lingueglia et al., 2006). 
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Subsequently, further DEG/ENaC were identified in mammals. They were called acid 
sensing ion channels (ASICs) as these channels are gated by protons (Waldmann et al., 
1997b). ASICs are exclusively expressed in chordates. In mammals four genes code for the 
isoforms ASIC1a, ASIC2a, ASIC3 and ASIC4 (Waldmann et al., 1997b; Price et al., 1996; 
Waldmann et al., 1997a; Grunder et al., 2000). Furthermore, alternative splicing gives rise 
to the isoforms ASIC1b and 2b (Chen et al., 1998; Lingueglia et al., 1997). ASICs are pH-
sensors implied in various physiological or pathophysiological functions like the perception 
of pain after tissue acidosis (Krishtal, 2003), death of neurons under ischemic conditions 
(Xiong et al., 2004) or learning and memory (Wemmie et al., 2002).  
After the genomic sequence of C.elegans was resolved, eight putative new DEG/ENaC 
members, the FLRs were identified. They are characterized by a conserved cysteine-rich 
domain that is related, but distinct from the C. elegans degenerins (Mano and Driscoll, 
1999). This lead to the classification of these genes to a new subfamily that is named after 
flr-1 (fluoride resistant mutant -1) a gene identified in a screen for fluor-resistance (Katsura 
et al., 1994) that is involved in the control of defecation rhythm (Take-Uchi et al., 1998).  
In 1998, RPK ripped pocket (RPK) and pickpocket (PPK), two novel DEG/ENaC proteins 
from Drosophila melanogaster, were cloned and RPK was functionally expressed in 
Xenopus oocytes, where it generates an amiloride sensitive, sodium selective current 
(Adams et al., 1998). In total, the genome of Drosophila comprises 31 candidate genes 
related to DEG/ENaC proteins (Ben-Shahar, 2011). Some of these genes have been further 
characterised and the corresponding channels were shown to be implicated in several 
physiological functions such as detection of salt (ppk11, ppk19) (Liu et al., 2003) and 
pheromones (ppk25) (Lin et al., 2005) or mechanosensation (Zhong et al., 2010). 
A further family member expressed in mammals was cloned in 1998 from mouse and rat. It 
was named brain liver intestine Na+ channel (BLINaC) according to it expression pattern of 
its mRNA (Sakai et al., 1999). One year later, the human homologue was cloned and 
named INaC (intestine Na+ channel) (Schaefer et al., 2000). When expressed in Xenopus 
oocytes, BLINaC and INaC do not generate constitutive currents and their stimulus of 
activation remained unclear (Wiemuth and Gründer, 2010). Recently, the expression of 
BLINaC could be specified to cholangiocytes, epithelial cells lining bile ducts. Convenient to 
these findings, millimolar concentrations of bile acids robustly activated rat BLINaC and 
human INaC. Therefore, BLINaC and was renamed to BASIC (bile acid sensitive ion 
channel) (Wiemuth et al., 2012).  
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Finally, our group has cloned four new DEG/ENaC genes from the Cnidarian Hydra 
magnipapillata that were named hynac 1-4 (Hydra sodium channel) (Golubovic et al., 2007). 
In Hydra, expression of hynac 2-, -3 and -4 was confirmed at the base of the tentacles while 
hynac 1 likely encodes a pseudogene. The coexpression of two subunits, HyNaC2 and 3, in 
Xenopus oocytes lead to expression of an ion channel that is directly gated by two 
endogenous neuropeptides from the Hydra nervous system (see also 1.3 for a detailed 
 
 
Fig. 1: Phylogenetic tree of the DEG/ENaC ion channel superfamily. The subfamilies in vertebrates comprise 
ENaCs, ASICs, BLINaC and INaC. The subfamilies in invertebrates consist of the C. elegans degenerins (DEG, 
DEL, MEC, DEL) together with the not directly related FLRs. Further members are the Drosophila RPK and PPK 
channels, FaNaCs from different snail species and the HyNaCs from Hydra magnipapillata. 
(Adapted from: Golubovic et al., 2007) 
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description of the initial characterisation of HyNaC2/3). Until today, HyNaCs and the related 
FaNaC are the only known ionotropic neuropeptide receptors (Golubovic et al., 2007).  
 
1.1.1 Common features of DEG/ENaCs  
With regard to their expression pattern, physiological function and their stimulus of 
activation the individual DEG/ENaC family members are diverse. However, all known 
DEG/ENaCs share common characteristics: 1) They are only present in multicellular 
animals (metazoa), 2) all channels are selective for sodium and 3) can be blocked by 
amiloride (Kellenberger and Schild, 2002).  
DEG/ENaCs are characterized by their high degree of sequence homology. The size of a 
channel subunit ranges from ≈530 to ≈740 amino acids (Kellenberger and Schild, 2002). 
Sequence identity between different DEG/ENaC subfamilies is ≈15-30%, the amino acid 
identity within the subfamilies varies from ≈30-65% (Kellenberger and Schild, 2002). In 
HyNaCs, the subunits HyNaC3 and 4 are the closest relatives and share 60% identical 
amino acids; identity between HyNaC2 and subunits 3 or 4 is ≈28%.  
Fig. 2 shows a scheme of a typical DEG/ENaC subunit, domains and motifs that are 
conserved between family members are also depicted. Each subunit consists of two 
conserved transmembrane domains (M1 and M2) of approx. 20 amino acids length, 
interconnected via a large extracellular loop typically representing two third of the whole 
protein (Kellenberger and Schild, 2002). The intracellular N- and C- termini are generally 
rather short and consist in HyNaC 2-4 of ≈ 20 -70 amino acids (Golubovic et al., 2007). Fully 
conserved motifs are a HG (His-Gly) motif, located intracellularly close to the M1 region and 
a FPxxTxC consensus sequence in the post M1 region. The extracellular loop contains two 
cysteine-rich domains (CRD II and III) conserved in all family members. Other regions are 
only conserved within subfamilies like the CRD I region, which is unique to the C.elegans 
degenerins or a prolin-rich consensus motif (PY), conserved between ENaC subunits 
(Kellenberger and Schild, 2002). 
In the extracellular domain, in close proximity to M2, the deg position is located, a 
conserved residue harbouring an alanin or glycin. Replacement of this residue by amino 
acids with larger side chains induces hyperactivation in most DEG/ENaC channels 
(Kellenberger and Schild, 2002). The mutation was first described for the C. elegans 
degenerins DEG-1 and MEC-4 were it causes degeneration of touch receptor neurons 
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(Chalfie and Wolinsky, 1990; Driscoll and Chalfie, 1991). Examples for channels that are 
activated by the “DEG-mutation” are BLINaC (Sakai et al., 1999) and INaC (Schaefer et al., 
2000), RPK (Adams et al., 1998), ASIC1a and 2a (Waldmann and Lazdunski, 1998) and 
HyNaCs (unpublished data).  
As mentioned above, a collective and name giving feature of DEG/ENaCs is their selectivity 
for Na+. However, the selectivity for Na+ over K+ can vary between individual family 
members. For example αβγENaC almost exclusively conducts Na+, its PNa/PK value is >100 
(Kellenberger et al., 1999), whereas ASIC1b (Chen et al., 1998) is only slightly selective for 
sodium with a PNa/PK value of ≈3 (Chen et al., 1998). In sharkASIC1b (Springauf and 
Gründer, 2010), ASIC3 (Lingueglia et al., 1997) and BASIC (Wiemuth and Gründer, 2010; 
Wiemuth et al., 2012) the coexistence of an unselective state and a Na+-selective state had 
been reported. A permeability for Ca2+ is only described for the mammalian ASIC1a 
(Bässler et al., 2001) and for MEC-4(d) (Driscoll and Chalfie, 1991), a mutant DEG/ENaC 
channel from C.elegans. For both channels, the permeability for Ca2+ is very weak (Bianchi 
et al., 2004; Samways et al., 2009) and the wildtype MEC-4 is not Ca2+ permeable 
(Goodman et al., 2002; O'Hagan et al., 2005). 
 
 
Fig. 2: Scheme of a typical DEG/ENaC subunit showing conserved motifs and regions. 
(Adapted from: Kellenberger and Schild, 2002) 
N C
M1 M2 plasma  membrane
HG
deg position
pre-M2
post M1
CRD Iunique to  degenerins
CRD II
CRD III
PY
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The discovery of the crystal structure of ASIC 1a shows that DEG/ENaCs assemble as 
trimers (Jasti et al., 2007). Moreover, the crystal structure confirmed several older studies 
suggesting the second transmembrane domain as selectivity filter and pore lining domain of 
DEG/ENaCs (Jasti et al., 2007; Gonzales et al., 2009; Gründer and Chen, 2010). 
 
1.1.2 The crystral structure of ASIC1 reveals the trimeric 
structure of DEG/ENaCs  
In 2007, the first crystal structure of chicken ASIC1 was resolved at 1.9 Å resolution (Jasti et 
al., 2007). Although the first structure brought an invaluable progress for the further 
research on ASICs and related channels, the exact architecture of a functional channel 
remained elusive as the crystal was obtained from a non-functional deletion mutant lacking 
the intracellular N- and C-termini. Subsequently, the crystal structure of a functional, sodium 
selective chicken ASIC1 was obtained at 3 Å resolution that still missed most residues of 
the C-terminus but contained the N-terminus which is known to be important for channel 
gating (Gonzales et al., 2009). The main advancement of the second crystal structure was a 
more precise insight in the arrangement of the transmembrane domains. ASIC1 
desensitizes at acidic pH values. As both crystals were obtained at low pH, they provide a 
snapshot of the desensitized state of the channel. Recently, the structures of ASIC1 in 
complex with psalmotoxin for two open state conformations were resolved (Baconguis and 
Gouaux, 2012). Psalmotoxin is a peptide toxin derived from the South American tarantula. It 
acts on ASIC1a by increasing the channels apparent affinity for protons (Chen et al., 2006a) 
and has either agonistic or antagonistic effects depending on species and splice variant of 
ASIC1(Baconguis and Gouaux, 2012). Depending on the pH at which the crystals were 
derived, two different open state conformations were resolved: One sodium selective state 
(obtained at low pH) and one unselelective state (obtained at neutral pH). To date, the sum 
of all available structures allow the reconstruction of the transitions occurring between 
channel opening and desensitisation. The structure of the closed and non-desensitized 
state is still unknown. 
Before the first ASIC structure was resolved, the subunit stoichiometry of DEG/ENaCs was 
controversially discussed with authors postulating tetrameric (Firsov et al., 1998; Coscoy et 
al., 1998; Dijkink et al., 2002) or even nonameric assemblies (Snyder et al., 1998). 
However, the first crystal structure proofed the trimeric assembly of ASIC1a (Jasti et al., 
Introduction 
11 
2007) and, by extension, this stochiometry is most likely valid for all DEG/ENaCs (Gonzales 
et al., 2009). Fig. 3A shows the trimeric structure of chicken ASIC1a in complex with 
psalmotoxin and in Fig. 3B the schematic drawing sketches the composition of a single 
subunit together with individual subdomains and important regions. 
 
Each subunit resembles an upright forearm (formed by TM1 and TM2) and a clenched hand 
(formed by the ECD). The hand is subdivided in a palm, finger, thumb, knuckle and β-ball 
domain. Both TM-domains directly connect to the palm domain which spans the entire 
height of the ECM and also connects to the thumb domain (Jasti et al., 2007). As many 
disulphide bonds localize to the thumb, it has a rigid structure. The thumb domain is 
implicated in transferring conformational changes to the transmembrane ion pore via an 
aromatic interaction between Trp 288 (thumb) and Tyr 72 (TM1) by forming a molecular 
“ball-and-socket joint” (Li et al., 2009; Gründer and Chen, 2010). As binding site for protons, 
the natural ligands of ASIC1, a region clustering several acidic residues has been proposed. 
This “acidic pocket” is formed by intersubunit contacts between the thumb, β-ball and finger 
domains together with residues from the palm domain (Jasti et al., 2007 see Fig. 3B). 
 
 
Fig. 3: (A) Crystal structure of ASIC1 at pH 5.5 in complex with psalmotoxin viewed parallel to the membrane. 
Each of the three subunits is in a different colour and psalmotoxin is shown in purple in solvent-accessible 
surface representation (from: Baconguis et al.; 2012). (B) Model of the transmembrane topology of an individual 
ASIC1 subunit based on the crystal structure from Jasti et al., 2007. The insets highlight the individual domains 
of the extracellular loop, the acidic pocket, the putative Ca2+ binding site and the ball-and-socket joint. The 
residues are numbered according to the chicken ASIC1 sequence (from: Gründer and Chen, 2010). 
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Consistent with this, the acidic pocket forms a cavity which is also the binding spot of 
psalmotoxin (Baconguis and Gouaux, 2012). In the desensitized state of the channel, the α-
helices of the transmembrane segments are symmetrically arranged and the TM1 helices 
make most contacts with the lipid bilayer while the TM2 helices line the ion pore (Gonzales 
et al., 2009). The ion conduction pathway is occluded by a constriction formed by the 
crossing of the TM2 helices at about halfway of the membrane bilayer (Fig. 4A).  
This constriction forms the desensitisation gate which is defined on the extracellular side by 
Asp 433 (Gonzales et al., 2009). Asp 433 is conserved among DEG/ENaCs and is 
implicated in open channel Ca2+ block of ASIC1a - possibly by tight binding of Ca2+ to this 
residue thereby occluding the ion pore. Substitution of this residue by cysteine almost 
completely abolishes the blocking effect of Ca2+ in ASIC1a (Paukert et al., 2004). According 
to this, a Cs+ ion can bind Asp 433 in the desensitized and in the open conformation of the 
channel (Gonzales et al., 2009; Baconguis and Gouaux, 2012). Directly above Asp 433, the 
structure reveals three lateral fenestrations trough witch ions might enter the ion pore (Fig. 
4A). 
 
 
Fig. 4: (A) Structure of the TM-region of chicken ASIC1 in the desensitized state. The ion conduction pathway is 
occluded by the crossing of the three TM2 domains. Asp 433 is the position of the desensitisation gate. The 
arrow illustrates one of the three putative entry sites for cations (adapted from: Gonzales et al., 2009). (B) Top, 
comparison of the transmembrane domains from the high pH (left) and low pH (right) state structures. The 
desensitized states are shown in grey. Transmembrane domains are shown from the extracellular site. Bottom, 
mapping of a solvent accessible pathway along the threefold axis for the high- and low pH states. Arrows 
indicate the constriction of the pathway in the low pH state (adapted from: Baconguis et al., 2012). 
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The structure of ASIC1a in complex with psalmotoxin revealed two different open channel 
conformations (Fig. 4B). At high pH, ASIC1a is unselective for monovalent cations and 
forms a large, threefold symmetric pore lined by both TM-domains of each subunit. The 
pore has its smallest diameter of 10 Å near the conserved Asp 433 and conducts cations as 
large as NMDG+. In contrast to this, at low pH the ion pore of ASIC1a selects for sodium 
and the second transmembrane domain of one subunit is shifted by ≈4 residues to the 
extracellular side relative to the other subunits conferring axial asymmetry onto the pore 
(Gründer and Augustinowski, 2012). The three TM2 domains together with the TM1 of one 
subunit line the ion conduction pathway. Na+ is supposed to pass the pore in a fully 
hydrated state (Baconguis and Gouaux, 2012). At low pH, the ion pore has an elliptical 
shape with its narrowest constriction of ≈5-7 Å at Leu 440 which is close to the conserved 
“GAS motif” that has been previously identified as selectivity filter of many DEG/ENaCs 
(Kellenberger and Schild, 2002; Li et al., 2011; Baconguis and Gouaux, 2012).  
In summary, the available crystal structures nicely demonstrate the different conformations 
between the desensitized and the two open states of ASIC1a. For a more complete 
understanding of the transitions during channel gating, it would be interesting to resolve the 
structure of ASIC1a also in the closed and non-desensitized state. 
 
1.1.3 Identification of FaNaC - the first peptide-gated ion channel 
Most effects of neuropeptides in the nervous system of vertebrates and invertebrates are 
either of modulatory nature, or slow and frequently depend on G-protein coupled receptors 
(GPCRs) (Cottrell, 1997). The first evidence for an ion channel that is directly gated by 
neuropeptides came from outside-out patch-clamp experiments in C2 neurons from Helix 
aspersa. In these experiments, application of FMRFamide elicited unitary Na+ inward 
currents that were insensitive to inhibitors of GPCRs but could be blocked by amiloride 
(Cottrell et al., 1990; Green et al., 1994; for review see Cottrell, 1997). Subsequently, the 
FMRFamide-gated sodium channel (HaFaNaC) was cloned from Helix aspersa by 
homology to known DEG/ENaC subunits (Lingueglia et al., 1995). When expressed in 
Xenopus Oocytes, HaFaNaC is directly gated by micromolar concentrations of FMRFamide 
(Fig. 5) and shows large, partly desensitizising Na+ selective currents, which can be blocked 
by amiloride. Hence, HaFaNaC is the first identified peptide-gated ion channel. Its ligand, 
FMRFamide (Phe-Met-Arg-Phe-NH2) belongs to a class of neuropeptides present in the 
nervous system of many invertebrates. In addition to activate FaNaC, FMRFamide has 
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been implicated to participate in several physiological 
functions which are mediated, in most instances, by 
binding to GPCRs (Askwith et al., 2000a).  
To date, further FaNaCs have been cloned and 
functionally expressed from the molluscs Lymnea 
stagnalis (Perry et al., 2001), Heliosoma trivolis 
(Jeziorski et al., 2000) and Aplysia kurodai (Furukawa et 
al., 2006). All known FaNaCs are closely related and 
share about 60% amino acid identity and highly 
conserved regions within the extracellular loop and transmembrane regions (Furukawa et 
al., 2006). Apparent affinities for the ligand FMRFamide range from ≈2 µM for HaFaNaC 
(from Helix aspersa) (Lingueglia et al., 1995) to ≈70 µM for HtFaNaC (from Heliosoa trivolis) 
(Jeziorski et al., 2000). These differences in the apparent affinity were used in a chimeric 
approach to identify the ligand-binding site of FaNaCs. Although the exact binding site could 
not be determined, it was postulated that an important region which controls the apparent 
affinity for the peptide is situated in the N-terminal region of the extracellular loop close to 
the first transmembrane domain (Cottrell et al., 2001). To this day, the physiological role of 
FaNaCs is unknown. 
 
1.1.4 Physiological roles of RFamides and related peptides in 
the vertebrate nervous system 
In general, the release and subsequent binding of a neurotransmitter to an ionotropic or 
metabotropic receptor mediates the chemical signal transduction in the nervous system. 
Ionotropic receptors are ion channels that typically get activated by binding one of the 
classical small molecule transmitters like acetylcholine, GABA or glutamate. Due to the 
direct propagation of ligand-binding to channel-gating, ionotropic receptors are especially 
suited to transmit fast and short-lasting signals. On the other hand, metabotropic GPRCs 
activate second-messenger cascades and typically transmit slow, modulatory and long-
lasting signals. As general rule of thumb, the classical small molecule neurotransmitter can 
bind and activate both, ionotropic and metabotropic receptors, while neuropeptides activate 
metabotropic receptors but have only modulatory impact on ionotropic receptors (Pierobon, 
2012).  
 
Fig. 5: Characteristic current trace of 
HaFaNaC recorded from Xenopus 
occytes. 
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However, as mentioned before, two invertebrate ionotropic receptors from the DEG/ENaC 
family form an exception from this rule, as they are directly gated by neuropeptides: The 
FMRFamide-gated FaNaC from molluscs (Lingueglia et al., 1995) and the HydraRFamide 
gated HyNaCs from Hydra (Golubovic et al., 2007). 
The discovery of peptide-gated FaNaCs stimulated the research for mammalian peptide-
gated ion channels but until now, no such receptor has been identified. However, 
FMRFamides and HydraRFamides modulate mammalian ASICs, which are closely related 
to FaNaCs and HyNaCs. For example Askwith et al. demonstrated that application of 
FMRFamide slowed the desensitization time-constant of ASIC1a, 1b and 3 (Fig. 6A) 
(Askwith et al., 2000a). A similar effect was reported for the HydraRFamides I-IV on ASIC 3 
currents (Fig. 6B), (Golubovic et al., 2007).  
FMRFamide and HydraRFamides are not present in the mammalian nervous system 
(Lingueglia et al., 2006). However, related RFamide peptides, the neuropeptide FF (NPFF), 
the neuropeptide AF (NPAF) and neuropeptide SF (NPSF), which all derive from a common 
precursor, were identified in mammals by their similarity with FMRFamide (Perry et al., 
1997; Vilim et al., 1999). These neuropeptides have been implicated in participating in 
various processes like pain modulation, opiate perception, cardiovascular regulation and 
neuroendocrine function (Panula et al., 1996; 1999; Roumy and Zajac, 1998). 
 Most of the observed effects seem to rely on G-protein coupled receptors but for NPFF and 
NPSF a direct modulation of ASIC3 currents, which is similar to the effect of FMRFamide, 
has been reported (Askwith et al., 2000b; Deval et al., 2003). These findings are in 
agreement with the participation of NPFF, NPSF and ASIC3 in the response to painful 
 
Fig. 6: (A) Application of 50 µM FMRFamide slows desensitization of ASIC1a (from: Askwith et al., 2000). (B) 
Similarly, application of 50 µM HydraRFamides I-VI modulates ASIC3 currents (from: Golubovic et al., 2007). 
Both measurements show recordings from Xenopus Oocytes expressing ASIC1a and ASIC3, respectively. 
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stimuli and correlate with reports of increased expression of these proteins during chronic 
inflammation in mammals (for review see Lingueglia et al., 2006). 
Besides the neuropeptides mentioned above, further peptides with modulatory effects on 
ASICs were discovered. For example the opioid peptide dynorphin, which is abundantly 
expressed in the CNS, was shown to enhance activity of ASIC1a by the inhibition of steady-
state desensitization (Sherwood and Askwith, 2009). Recently, it was proposed that 
mutations around the acidic pocket (i.e around H173) are involved in this modulation by 
dynorphin (Frey et al., 2012).  
Furthermore, an interaction of ASIC1a with the painful tarantula peptide toxin psalmotoxin1 
was reported (Escoubas et al., 2000). It was shown that the toxin shifts the steady-state 
desensitisation of ASIC1a to lower H+ concentrations (Chen et al., 2006a).  
 
1.2. The Hydra nervous system 
Hydra belongs to the phylum Cnidaria, which is considered as the earliest phylum in which 
a nervous system has evolved. The features and mechanisms of function of this 
evolutionary old nervous system are considered as basic, fundamental features of higher 
developed brains. Therefore Cnidarians became a model system in the study of the 
evolution of the nervous system (for reviews see Kass-Simon and Pierobon, 2007; 
Pierobon, 2012).  
From the anatomical point of view, the Cnidarian nervous system is very simple. The 
neurons are connected to one another forming a nerve net which is composed of two 
distinguishable cell types: (1) sensory neurons which posses an apical cilium and project to 
the surface of the epithelial cell layer and (2) the ganglion or interneuronal cells which lie 
parallel to muscle processes and are located at the basal end of epithelial cells (Pierobon, 
2012). In Hydra, the nerve net is not homogenously diffuse but exhibits condensed 
structures especially in the head and foot region. For example, a concentration of neurons 
is observed at the apex of the hypostome region of Hydra oligactis and, in addition, a nerve 
ring is formed that runs circumferentially in the lower hypostome (Fig. 7) (Koizumi, 2007). 
An unusual property of the Cnidarian nervous system is its dynamic structure. Neurons 
differentiate continuously from the multipotent stem cells among the interstitial cells along 
the entire length of the animal (Bode, 1992). They become integrated into the existing nerve 
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net at the rate of epithelial cell division and migrate 
towards the extremities were they get finally lost 
together with the epithelial tissue. By this 
mechanism, the mash size as well as the number 
of neurons remains constant (Heimfeld and Bode, 
1986; Bode, 1992) .  
Although the Cnidarian nervous system is 
regarded as evolutionary old and simple, there is 
accumulating evidence that the simplicity of the 
nervous system is rather on the anatomical than 
on the biochemical level (Pierobon, 2012). The 
analysis of genomic data and the recent 
publication of the genome of Hydra and 
Nematostella revealed the complexity of the 
Cnidarian genomic repertoires and striking similarity to bilateria (Putnam et al., 2007; Anctil, 
2009; Chapman et al., 2010). Cnidarian neurons have been shown to be electrically 
excitable, they can exhibit action potentials and are connected by chemical synapses, gap 
junctions or synaptic bridges (Pierobon, 2012). 
One main interest in the study of the Cnidarian nervous system is the identification of the 
neurotransmitters this evolutionary old nervous system is using. Numerous studies 
employing histochemical, biochemical, immunocytochemical and behavioural approaches 
indicate that all classical small molecule neurotransmitter, involved in fast synaptic 
transmission in vertebrates, seem to be present in the Cnidarian nervous system as well 
(Kass-Simon and Pierobon, 2007). In Table 1, the body of evidence for the presence of 
these neurotransmitters is shown together with the individual detection method. Although 
the evidence for the existence of the classical transmitters is compelling and electron 
microscopic images document the presence of small clear vesicles in Cnidarians, many 
studies failed to proof that the identified substances really work as neurotransmitter. So far, 
in no instance it has been shown that a candidate transmitter meets all the traditionally 
accepted criteria for a neurotransmitter (Anderson and Trapido-Rosenthal, 2009).  
 
Fig. 7: Concentration of neurons in the 
hypostome region and formation of a nerve 
ring in Hydra oligactis. Whole mount staining 
with RFamide antiserum. (From: Koizumi, 
2007) 
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Similarly, the search for the receptors of these small molecule neurotransmitters has been 
intensively pursued (reviewed by Kass-Simon and Pierobon, 2007). For example, hints for 
the presence of both, ionotropic GABAA and metabotropic GABAB receptors were found in 
membrane preparations of Hydra vulgaris (Pierobon et al., 1995; Scappaticci and Kass-
Simon, 2008) and immunocytochemical studies localised NMDAR1 immunoreactivity in 
nerve cells, epitheliomuscular cells and nematocytes (Scappaticci et al., 2004; Scappaticci 
and Kass-Simon, 2008). In behavioural studies on Hydra vulgaris, application of glutamate, 
AMPA and kainate had excitatory effects in the ectodermal pacemaker systems providing 
hints for the presence of the corresponding receptors (Kass-Simon et al., 2003). However, 
molecular evidence for the existence of these receptors is still lacking. 
Recently, large progress in the search for classical chemical neurotransmission in 
Cnidarians was made with the sequencing of the genome of Nematostella vectensis (Anctil, 
2009). A subsequent genomic analysis suggests the presence of 12 apparent nicotinic 
acetylcholine receptors together with 5 genes coding for apparent acetylcholinesterases 
and 3 genes for choline-acetyltransferases. Similar, genes with homology to AMPA (6), 
Kainate (2) and NMDA (4) receptors were identified. In addition, the genome comprises 
genes with homology to GABAA (12) and GABAB (9) receptors. Furthermore, the analysis 
suggested the presence of purinergic P2X (2) receptors and the presence of receptors for 
biogenic amines, adenosine and NO (Anctil, 2009). In Hydra, the sequencing of the genome 
revealed the presence of nicotinic acetylcholinreceptors and other genes that are present at 
the neuromuscular junction in bilaterians. However, as other genes are missing it is unclear 
weather the neuromuscular junction in Hydra is really cholinergic (Chapman et al., 2010). 
Another recent study identified TRPA1 in sea anemones in the hair bundles of sensory 
 
Table 1: Experimental evidence for small melucule tranmitter in Hydra spec. 
(Adapted from: Kass-Simon and Pierobon, 2007) 
 
Summary of experimental evidence for the various substances in Cnidaria
Vesicles ACH Glutamate GABA Glycine E/NE 5HT NO EicosanoidsTaurine
Hydra spec. CD HPM IBPM IBPM BBP IBPMS
Catecholamines
HBP HBP BP BP
C=Clear vesicles,  D=Dense cored vesicles,  I= Immunicytochemistry,  H= Histochmeistry,  M= Molecular biology,  P=Pysiological/Behavioral e!ects,
S=Synaptic localistaion
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neurons that are associated with cnidocyst discharge and TRPA1 is also encoded in the 
genome of Hydra (Mahoney et al., 2011; Holstein, 2012). This suggests a possible role of 
TRPA1 in the discharge of nematocysts and is in accordance with the function of TRPA1 as 
mechanosensor in vertebrates (Holstein, 2012). 
Besides the accumulating evidence for the role of small molecule transmitters in both, fast 
and slow synaptic transmission, there is evidence for the ubiquitous presence of 
neuropeptides in the Cnidarian nervous system. Pioneering work in the identification of 
these Cnidarian neuropeptides came from Grimmelikhuizen and his co-workers in the early 
1980´s. In a series of studies using immuocytochemical approaches, they identified 
substance-P-like, neurotensin-like, bombesin-like, vasopressin/ocytocin-like and 
FMRFamide-like immunoreactivity in Hydra and other Cnidarians (Grimmelikhuijzen et al., 
1981a; 1981b; 1981c; 1982; Grimmelikhuijzen, 1983). Further studies led to the 
identification and resolution of the structure of numerous neuropeptides from different 
Cnidarian species (Fujisawa and Hayakawa, 2012).  
So far, all isolated neuropeptides share some structural hallmarks: They posses a C-
terminal amide group and frequently their N-termini contains protection groups like pyro-Glu 
residues or X-Pro sequences (Hansen et al., 2002). The biosynthetic pathways of Cnidarian 
neuropetides was also identified. Similar to mammalians, the neuropeptides are 
synthesized from precursor proteins, which are called preprohormones. By post-
translational cleavage they give rise to different neuropeptides that all share the same 
dipeptide-amide ending (Grimmelikhuijzen et al., 1996; Leviev et al., 1997; Darmer et al., 
1998). Table 2 shows a list of the known preprohormones together with their neuropeptides 
from Hydra.  
The HydraRFamides I-IV which were used in this work arise from the preprohormones A, B 
and C (Darmer et al., 1998). While preprohormones A gives rise to HydraRFamides I-IV 
preprohormone B codes for HydraRFamide I and II and preprohormone C only codes for 
seven copies of RFamide I (Darmer et al., 1998). A whole mount in situ hybridization with 
cRNA probes against the preprohormones A-D revealed that the individual preprohormones 
are expressed in different subsets of the Hydra nervous system. For example 
preprohormone A expression was localised in the hypostome, gastric region and peduncle 
whereas preprohormone C staining was only observed in tentacles (Hansen et al., 2002).  
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In addition, colocalisation of preprohormone A and E was found in the peduncle but not in 
other body regions. In summary, these findings suggest the presence of at least six 
neurochemical different classes of neurons in Hydra (Hansen et al., 2002).  
The HydraRFamides and several other neuropeptides were identified in dense-core vesicles 
associated with synaptic and non-synaptic release sites (Koizumi et al., 1989; 
Grimmelikhuijzen and Westfall, 1995). Although the physiological function of many 
Cnidarian neuropeptides remains elusive, behavioural effects have been reported for some 
of them. For example in sea anemones an either agonistic (AnthoRW-amides I and II), or 
antagonistic (Antho-KAamide and AnthoKIamide) effect on muscle contractions was 
observed (McFarlane et al., 1991; 1993). In another study, the anthozoan neuropeptide 
 
Table 2: Summary of the identified preprohormones together with their neuropeptides and localisation in Hydra. 
<Q designates C-terminal pyroglutamate. References: a) Mitgutsch et al., 1999; b) Hansen et al., 2000; c) 
Takahashi et al., 2000; d) Hansen et al., 2002; e) Takahashi et al., 2005; f) Hayakawa et al., 2007. 
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AnthoRWamide was shown to excite muscle contractions and simultaneous recordings from 
myoepithelial cells documented that the peptide increases an inward Ca2+ current (Cho and 
McFarlane, 1996). For the HydraRFamides and HydraLWamides behavioural and 
developmental effects in the Hydrozoan Hydractinia echinata were reported. Thereby, the 
two classes of neuropeptides seem to have antagonistic effects. HydraLWamides induced 
the metamorphosis of planula larvae into adult polyps and HydraRFamides inhibited it 
(Katsukura et al., 2003). Similarly, the migration of planula larvae is stimulated by 
HydraLWamides and suppressed by HydraRFamides (Katsukura et al., 2004). To date, the 
receptors of most Cnidarian neuropepides are unkown. However, the identification of ligand-
gated ion channels directly gated by HydraRFamides (Golubovic et al., 2007) and the 
presence of more than 100 putative genes coding for GPCRs (Fujisawa, 2008) suggest that 
the Cnidarian neuropeptides work by binding and activating both, ionotropic and 
metabotropic receptors.  
 
1.3. Identification of a peptide-gated DEG/ENaC from 
Hydra 
To identify evolutionary conserved features of the DEG/ENaC channel family, our group 
cloned four novel DEG/ENaC subunits from the freshwater polyp Hydra magnipapillata. 
These new subunits have been characterized previously in our group by Andjelko Golubovic 
(see Golubovic et al., 2007). A short summary of this characterisation is given below: 
The new DEG/ENaC members were named HyNaC1-4 (Hydra sodium channel). The 
subunits HyNaC3 and 4 are most closely related and share 60% identical amino acids; 
identity between HyNaC2 and subunits 3 or 4 is ≈ 28%. One of the cloned genes, hynac1, is 
most likely a pseudogene as it is lacking both, a methionine to initiate translation and a 
conserved N-terminal HG-motif common to all DEG/ENaC channels. Using an in situ 
hybridisation assay, the expression of hynac2-4 transcripts was detected at the base of the 
tentacles in adult Hydra polyps most likely in epitheliomuscular cells. Moreover, hynac2 and 
3 transcripts were observed in the budding region of growing polyps, whereas expression of 
HyNaC4 was observed at a later developmental stage, when buds detached from the 
mother polyp. The new HyNaC subunits were also investigated by TEVC measurements in 
Xenopus oocytes. Coexpression of HyNaC2 and 3 gave raise to an ion channel that is 
directly gated by two endogenous neuropeptides from Hydra, the HydraRFamides I and II 
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(Fig. 8A). Application of the HydraRFamides I and II induced inward currents (1-10 µA) that 
consisted of a transient peak and a non-desensitisizing sustained current component (Fig. 
8A). The HydraRFamides I and II activated the channel with an apparent affinity of 34 ± 9 
and 28 ± 4 µM, respectively (Fig. 8B). The related HydraRFamides III and VI failed to open 
the channel (Fig. 8A). Further characterisation revealed that repeated activation with 
HydraRFamides I and II led to a decrease in current amplitudes (Fig. 8C).  
 A similar effect had been reported previously for the related DEG/ENaC channel ASIC1a 
where the “run-down” of currents was named tachyphylaxis (Chen and Gründer, 2007). 
Similar to other DEG/ENaCs, HyNaC2/3 is blocked by amiloride but the efficacy of block 
was low (IC50= 540 ± 40 µM) (Fig. 8D). When extracellular Na+ was replaced by K+ or Li+, 
the current amplitudes were not significantly changed (Fig. 8E) suggesting that HyNaC2/3 is 
 
Fig. 8: (A) Currents elicited by HydraRFamides in Xenopus ocytes injected with HyNaC2 and 3. (B) 
Concentration-response curves for the HydraRFamides I and II. (C) Repeated application of HydraRFamides 
lead to a decreased response. (D) Concentration-response curve for the inhibition of HyNaC2/3 by amiloride. (E) 
Replacement of Na+ by K+ and Li+ did not significantly alter the current amplitudes. 
(From: Golubovic et al., 2007) 
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an unselective ion channel, which is an atypical feature within the DEG/ENaC family as 
other members are selective for Na+ (Kellenberger and Schild, 2002).  
Taken together, these results confirmed HyNaC2/3 as a new DEG/ENaC family member 
that is directly gated by endogenous neuropeptides. These findings were surprising as 
neuropeptides usually only have modulatory functions on ion channels. Indeed, HyNaCs 
and the related FaNaCs are the only known peptide-gated ion channels. 
However, the low affinity for amiloride and the lack of selectivity for sodium are unexpected 
findings as all known DEG/ENaC are sodium selective and sensitive for amiloride. This 
indicates that these features are either not evolutionary conserved among DEG/ENaC 
channels or that another subunit of the HyNaC2/3 heteromer might still be missing.  
 
Methods 
24 
II. Materials and Methods 
2.1 Materials 
2.1.3 Chemicals 
All standard chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), Merck 
(Darmstadt, Germany) and Roth (Karlsruhe, Germany) if not stated otherwise. 
 
2.1.3 Materials for molecular biology 
Ready to use materials: 
100 bp DNA-ladder  New England Biolabs, Ipswich, MA, USA 
1 kB GeneRuler DNA-ladder  Fermentas, St. Leon-Rot, Germany 
DEPC H2O  Carl Roth, Karlsruhe, Germany 
RedSafe DNA-staining dye  Chembio, Medford, NY, USA 
Super Signal ELISA Femto Maximum Thermo Fisher Scientific, Rockford, IL, USA 
Sensitivity Substrate   
dNTPs Carl Roth, Karlsruhe, Germany 
Fura2-AM Invitrogen, Carlsbad, CA, USA 
 
Enzymes: 
Restriction endonucleases New England Biolabs, Ipswich, MA, USA 
Taq DNA-polymerase New England Biolabs, Ipswich, MA, USA 
KAPA HiFi DNA-polymerase Peqlab, Erlangen, Germany 
Alkaline phosphatase New England Biolabs, Ipswich, MA, USA 
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Collagenase from  Sigma-Aldrich, St. Lois, MO, USA 
Clostridium histolyticum, Type II  
HydraRFamides I and II Genemed Synthesis, San Antonio, TX, USA 
 
Plasmid-vectors 
All constructs used for expression in Xenopus leavis oocytes were cloned into the custom-
made oocyte expression vector pRSSP-6009. The vector has a size of ≈3000 bp and 
carries an ampicilin resistance gene for positive selection of transformed E. coli cells. To 
facilitate robust expression of foreign genes in oocytes, the vector carries the 5´-untanslated 
region of the Xenopus ß-globin gene 5´-upstream of the multiple cloning site and a poly-A 
sequence ≈50 bp downstream of the cloning site. 
The probes for the in situ hybridisation assay (3.1.3) were cloned in the vector pBluescript 
from Stratagene (now AgilentTechnologies, Santa Clara, CA, USA) 
 
Top10 chemically competent E. coli 
Top10 competent cells (Invitrogen, Carlsbad, CA, USA) were used for all transformation 
reactions performed in this work. The phenotype of Top10 cells is similar to the DH10B 
strain and cells have a high transformation efficacy of 109 cfu/µg. 
 
Kits: 
Ligate-IT Rapid Ligation Kit  USB, Cleveland, OH, USA 
High Pure PCR Product Purification Kit   Roche, Mannheim, Germany 
High Pure PCR Cleanup Micro Kit  Roche, Mannheim, Germany 
High Pure Plasmid Isolation Kit   Roche, Mannheim, Germany 
mMESSAGE mMACHINE SP6  Ambion, Carlsbad; CA, USA 
RNA Transcription Kit 
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Antibodies:  
Anti-HA High Affinity  Roche, Mannheim, Germany 
Clone 3F10, rat IgG1 monoclonal  
Peroxidase-AffiniPure F(ab')2 Fragment  Jackson ImmunoResearch 
Goat Anti-Rat IgG (H+L)  West Grove, PA,  USA 
 
2.1.3 Solutions and buffers for molecular biology 
Agarose-Gels:  30 ml or 90 ml TAE-buffer 
 Add x g agarose 
  
LB-media 10 g tryptone 
 5g yeast extract 
 10 g NaCl 
 Add ddH20 to 1l; pH 7.5 
 Sterilized by autoclaving 
 
Agar-plates: 15g/l agarose 
 1 ml ampicilin (100 mg/ml) 
 Add LB-media to 1 l 
 Sterilzed by autoclaving, after cooling add ampicilin 
 
SOC-media: 20g tryptone 
 5 g yeast extract 
 2.5 ml of 1 M KCl 
 10 ml of 1M MgCl2 
 10ml of 1M MgSO4 
 Sterilized by autoclaving 
 Add 20ml of 1M glucose 
 Add ddH20 to 1 l 
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50 X TAE-buffer:  242 g Tris-Base 
 57.1 ml glacial acid (100%) 
 100 ml 0.5 M EDTA 
 Add ddH2O to 1 l 
 
2.1.3 List of primers 
All PCR primers were ordered from MWG-Biotech AG, Ebersberg, Germany. Working 
concentration was 10 pmol/µl. The primers used in this work are listed below: 
 
Name Sequence Purpose 
Hy2-HA-up 
5´-CGT ACG ACG TTC CAG ATT ATG CCG ATA TTC 
AAG GAG AAG AAC-3´ 
Hy2-HA-lo 
5´-AAT CTG GAA CGT CGT ACG GAT AGA ATC CTG 
GAT TTT CTA AAT TG-3 
To insert a HA-epitope in the 
extracellular loop of HyNaC2. 
Hy2-430_D-C-QC-
up 
5´-GAT TTT TAC AAG CTT ATT GGT TGT GTC GGA 
GGT CAA CTT GGT TTG C-3´ 
Hy2-430_D-C-QC-lo 
5´-GCA AAC CAA GTT GAC CTC CGA CAC AAC CAA 
TAA GCT TGT AAA AAT C-3 
Quick-Change primer for 
HyNaC2_D-C 
Hy3_D-C-Fl-up 5´-CAA CAC TAT GAA TAC TAT AGA G-3 
Flanking primer for 
HyNaC3_D-C 
Hy5-437_D-C-up 5´-GTT TCT TGG TTG TAT GGG AGG TGA AAT TG-3 
Hy5-437_D-C-lo 5´-CCT CCC ATA CAA CCA AGA AAC TG-3´ 
Mutagenesis primer for 
HyNaC5_D-C 
Hy5_D-C-FL-up 5´-GGG GAA AAG ATG TCC AGT AG-3´ 
Flanking primer for 
HyNaC3_D-C 
Hy3-432_D-C-up 5`-GGC TAG GAT GTG TTG GTG GTC AGA TAG-3 
Hy3-432_D-C-lo 5´-CCA CCA ACA CAT CCT AGC CAC ACC-3´ 
Mutagenesis primer for 
HyNaC3_D-C 
SP6-upper 5´-AGG TGA CAC TAT AGA AAT AC-3´ 
PSP3-lower 5´-CTC AGA GAT TCG ATG TAT-3´ 
Primers, flanking the MCS of 
the oocyte expression vector 
pRSSP-6009 
Table 3: List of primers used in this thesis. 
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2.2 Molecular biological methods 
2.2.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to analyze DNA- and RNA-fragments according to 
their size and concentration. Moreover, preparative agarose gels were used to isolate 
individual DNA-fragments. Depending on the size of the analyzed DNA or RNA, gels with 
0.8-2% agarose solved in 1x TAE-buffer were used. The mixture was boiled in a microwave 
to dissolve the agarose and 1.5 µl “Red Safe” staining dye per 30 ml gel was added. Wells 
were formed with plastic combs of appropriate size. After cooling, the gels were placed in 
running chambers (Bio-Rad) filled with 1x TAE as running buffer. Before loading the gel, 
samples were mixed with 6x gel-loading buffer and RNA probes were additionally incubated 
at 65°C for 10 min to minimize formation of secondary RNA structures. A 100 bp or 1 kb 
DNA-ladder was used as molecular weight standard. Gel chambers were connected to a 
power supply (Power Pac 300; Bio-Rad) and run at 80-120 V for 20-45 min. Probes were 
visualized under a UV-transilluminator (Gel Doc XR, Bio-Rad) and analyzed using the 
software Quantitiy-One 4.6.1 (Bio-Rad). 
 
2.2.2 Purification of DNA 
The purification of DNA from agarose gels, PCR products and restriction enzyme digests 
was carried out with the “High Pure PCR Product Purification Kit” (Roche) according to the 
manufacturers instructions. DNA from PCR reactions and restriction enzyme digests were 
purified directly with the provided columns. For the recovery of DNA from agarose gels, 
bands of the expected size were excised with a scalpel under UV-light and transferred into 
1.5 ml reaction tubes. To solubilise the agarose, a threefold (w/w) excess of the provided 
solubilisation buffer was added and the gel slices were incubated at 65°C for 10 min in a 
shaking incubator (Thermo Mixer, Eppendorf). After this solubilisation step, the extracted 
DNA was loaded on the columns and purified according to the manufactures manual.  
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2.2.3 Restriction digest of DNA 
All restriction digests were carried out with restriction endonucleases (New England 
Biolabs) according to the manufacturer’s recommendations using the provided buffers and 
solutions. 10 U of enzyme were used to digest 1 µg of DNA. Restriction digests were carried 
out at the recommended temperature for 1-2 hours in a shaking-incubator (Thermo Mixer, 
Eppendorf). The DNA was subsequently checked for complete digestion by agarose gel 
electrophoresis. 
 
2.2.4 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) was used to generate all HyNaC mutants and for the 
identification of positive clones after transformation of heat-competent E. coli bacteria. PCR 
reactions were performed with a T 3000 thermocycler (Biometra).  
 
2.2.4.1 Inserting mutations by recombinant PCR 
All HyNaC mutants except HyNaC2_D-C were generated by recombinant PCR. With the 
recombinant PCR technique, a site directed mutagenesis or a site directed insertion of a 
custom DNA sequence was performed in three PCR reactions: 
In the first step of recombinant PCR, two individual PCR reactions were performed. For 
each PCR of the first step, a primer-pair consisting of a gene-specific primer and a 
mutagenic primer was used. While the exact binding site of the gene specific primer was 
arbitrary, the mutagenic primers had two features: 1) they carried the desired mutation; 2) 
the primer design gave rise to PCR products with overlapping sequences at the mutation 
site. 
With this primer design, the two PCR products from the first step hybridized at mutation site. 
This feature was used in a third PCR reaction in which both PCR products from the first step 
were corporately used as template. The gene specific primers from the first two rounds of 
PCR were used to amplify the final PCR fragment that was flanked by the gene specific 
primers and carried the desired mutation. Subsequently, the mutated PCR fragment was 
inserted into the vector carrying the wt construct by cutting vector and PCR fragment with 
the same two restriction enzymes to facilitate site directed ligation of the fragment into the 
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vector. Afterwards, the PCR fragment was inserted into the target vector in a ligation 
reaction (see 2.2.5). 
 
PCR (50 µl reaction volume) was performed with the proofreading “KappaHiFi polymerase” 
(Peqlab). PCR products from the first step were loaded on a preparative 1% agarose gel 
and fragments of expected size were excised with a scalpel under dimmed UV-light and 
purified with the “High Pure PCR Product purification Kit” (Roche) (see 2.2.2). 1 µl purified 
DNA from each PCR reaction was used as template for the third PCR. The PCR product 
was again loaded on an agarose gel and the DNA-fragment of expected size was excised 
and purified.  
To insert the mutated PCR fragment into the vector carrying the wildtype construct, 0.5 µg 
vector and the PCR fragment were cut with two different restriction enzymes creating sticky 
ends. Both restriction digests were loaded on a preparative agarose gel and bands of 
expected size were excised and purified. Following this step, both products were ligated 
(see 2.2.5) and the ligation product was subsequently used for transformation of competent 
Top10 E. coli cells (see 2.2.6). The success of mutagenesis was verified by DNA-
sequencing (see 2.2.8). 
 
Pipetting scheme for recombinant PCR mutagenesis: 
5x KAPAHiFi polymerase buffer  10 µl 
Template DNA ≈ 10 ng   1 µl 
Forward primer (10 pmol/µl)   1.5 µl 
Reverse primer (10 pmol/µl)   1.5 µl 
dNTPs (10 mM/µl each)   1µl 
KAPAHiFi polymerase (1 U/µl)  1 µl 
ddH2O      34 µL 
Reaction volume:    50 µl 
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 PCR protocol for recombinant PCR mutagenesis: 
 
 
 
 
 
 
 
 
 
 
2.2.4.2 Quick-Change mutagenesis 
In this work, the Quick-Change mutagenesis was used to create the HyNaC2_D-C mutant. 
Quick-Change was originally invented by the company Stratgene as an in vitro method to 
induce site directed point mutations or single amino acid changes into a plasmid in just one 
PCR reaction.  
For Quick-Change mutagenesis, complementary primers of 25-50 bp length that have a Tm 
≥ 75°C and carry the desired mutation in the middle of their sequence are used (see 2.1.3). 
The whole plasmid is amplified in a single standard PCR reaction with a proofreading 
polymerase. By this procedure a “new”, nicked plasmid containing the desired mutation is 
synthesized. The “new” PCR-generated plasmid is unmethylated, whereas the DNA from 
the template plasmid is methylated as it orginates from E. coli cultures. In the next step, the 
template plasmid is removed by means of the restriction enzyme Dpn I, which selectively 
digests methylated and hemimethylated DNA. Subsequently, the nicked mutated plasmid is 
transformed into competent TOP10 E. coli cells that repair the nick in the mutated plasmid.   
Step Temperature Time Cycles 
Initial denaturation 95°C 180 s 1 
Denaturation 98°C 20 s 
Annealing Tm ±10°C 30 s 
Elongation 72°C 30 s/kb  
16-20 
Final elongation 72°C 180 s 1 
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Pipetting scheme for the Quick-Change mutagenesis:  
 
5x KAPAHiFi polymerase buffer   10 µl 
Template plasmid DNA (5-, 10- or 20 ng)  x µl 
Mutagenesis Primer A (125 ng)   x µl 
Mutagenesis Primer B (125 ng)   x µl 
dNTPs (10 mM each)     1 µl 
ddH2O       x µL 
Reaction volume:    50 µl 
 
PCR protocol for the Quick-Change mutagenesis: 
 
Segment Cycles Temperature Time 
      1 1 95°C 120 s 
98°C 20 s 
55°C 60 s 2 16 
72°C 1min/kb plasmid length 
 
After thermocycling, 1 µl Dpn I (10 U/µl) was directly added to the PCR reaction. Dpn I 
treatment was for 1 h at 37°C. Subsequently, 1 µl of the Dpn I treated DNA was used for 
transformation of competent Top10 E. coli cells (see 2.2.6). The success of Quick-Change 
mutagenesis was verified by DNA-sequencing (see 2.2.8). 
 
 
Fig. 9: Principle of the Quick-Change mutagenesis. (Adapted from: Stratagene™ Quick-Change manual)	  
 
Plasmid
Thermocycling
desired mutation
Mutagenic primers
Dpn I treatment
Mutated  
plasmid
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Transformation
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2.2.5 Ligation of PCR fragments into plasmid vectors 
In the ligation reaction, the enzyme ligase catalyzes the ATP-depended formation of two 
phosphodiester bonds between the free 3´-hydroxy and 5´-phosphate endings between 
vector and insert. To ligate a PCR fragment (insert) into a plasmid vector, ≈0.5 µg vector 
and insert were cut with two restriction endonucleases creating „sticky ends“ for 2 hours. To 
prevent self ligation of the vector, 5 U of alkaline phosphatase was added to the restriction 
enzyme digest for 20 min. Subsequently, the digested vector and insert were loaded on a 
preparative agarose gel and bands of expected size were cut out with a scalpel and purified 
with the “High Pure DNA Purification Kit” (Roche) (see 2.2.2). For the ligation reaction, 
approx. 100 ng vector was mixed with a 3-fold molar excess of insert. This mixing ratio was 
estimated by analytical agarose gel electrophoresis. The ligation reaction was carried out 
with the “Ligate IT Rapid Ligation Kit” (USB Cooperation) for 10 min according to the 
manufacturers instructions. Subsequently, the ligated plasmid was used for transformation 
of chemically competent TOP10 E. coli cells (see 2.2.6).  
 
2.2.6 Transformation of chemically competent E. coli 
To amplify DNA-plasmids, chemically competent TOP10 E. coli cells were used (Invitrogen) 
that were stored in aliquots of 50 µl at -80°C. For transformation, the cells were carefully 
thawed on ice for 10 min. Either 50 ng of plasmid DNA or 10 µl of a ligation reaction (see 
2.2.5) were carefully added to the cells followed by further incubation on ice for 30 min. After 
a heat shock (42°C for 45 s), 250 µl of SOC-media (preheated to 37°C) was added and the 
cells were incubated at 37°C for 60 min in a shaking-incubator at 220 rpm. The cells were 
then centrifuged (5000 x g, 5 min at room temperature) and the supernatant was removed. 
The cells were resuspended in 100 µl LB-media and spread on agar plates containing 
ampicilin for selective growth of transformed bacteria. The plates were incubated at 37°C for 
≈12 hours. Ampicilin resistant colonies were then screened for the expression of the 
plasmid by colony-PCR. Further verification of positive clones was carried out by DNA-
Miniprep, followed by restriction enzyme analysis or DNA-sequencing. Positive clones were 
stored either as gylcerol stocks (LB-medium containing 25% (v/v) glycerol) or purified by 
DNA-Miniprep and stored as plasmid-DNA at -20°C. 
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2.2.7 Isolation of plasmid-DNA 
The isolation of plasmid-DNA from transformed cells was carried out by DNA-Miniprep. In 
the first step, 3 ml LB-medium containing 3 µl ampicilin (100 mg/ml) was inoculated with a 
single bacterial colony carrying the desired plasmid. The culture was incubated over night at 
37°C at 220 rpm in a shaking incubator. The cultures were then pelleted by centrifugation 
(5000 x g for 5 min) and the plasmid preparation was performed with the “High Pure 
Plasmid Isolation Kit” (Roche) according to the manufacturers instructions. Finally, 
concentration and purity of the DNA was analyzed by UV-Vis spectroscopy.  
 
2.2.8 Sequencing of DNA 
All HyNaC constructs were entirely sequenced prior to cRNA synthesis. DNA-sequencing 
was carried out by MWG-Biotech, Ebersberg, Germany. As sequencing probes 1 µg purified 
DNA, diluted in 15 µl ddH2O, was sent to the company. As sequencing primers SP6 and 
PSP3, which bind up- and downstream of the multiple cloning site of the oocyte expression 
vector pRSSP-6009, were used. Results were downloaded from the company’s website and 
analyzed using the software Lasergene Ver. 8.0 (DNASTAR, Madison, WI, USA). 
 
2.2.9 Determination of surface expression 
To quantify the surface expression of different HyNaC subunit combinations, a 
bioluminescence assay was performed. The principle of this assay is based on the insertion 
of a hemagglutinin (HA) epitope of the influenca virus into the extracellular loop of the 
membrane protein of interest. By means of this, the incorporation of the tagged protein in 
the extracellular membrane can be detected with an anti-HA monoclonal antibody. 
Subsequently, a second horseradish-peroxidase-coupled antibody is applied which detects 
the primary antibody. The horseradish-peroxidase from the secondary antibody 
enzymatically activates a chemiluminescent substrate and the evoked luminescence is 
measured with a luminometer. The luminescence is, in theory, proportional to the amount of 
bound secondary antibody and therefore proportional to the surface expression of the 
tagged protein. 
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To quantify surface expression, the (HA) epitope (YPYDVPDYA) was inserted in a non-
conserved region in the extracellular loop of HyNaC2 between residues Phe124 and Asp125 
by recombinant PCR (see 2.2.4.1). Oocytes were injected with a total of ≈3 ng cRNA. Two 
days after injection, the follicular membrane surrounding the oocytes was removed manually 
with forceps. The chemiluminescence measurement was performed four days after injection 
directly after immunollabeling. All of the following steps were carried out on ice: To block 
unspecific binding, oocytes were first incubated for 30 min in ND96 with 1% BSA. ND96 
solution contained (in mM): 96 NaCl; 2 KCl; 2 MgCl; 1.8 CaCl; 10 HEPES; pH: 7.4 adjusted 
with 1 NaOH. After block, oocytes were incubated for 60 min with 0.5 µg/mg rat monoclonal 
anti-HA antibody (Roche, Germany). Following incubation, six washing steps in ND96 with 
1% BSA removed unbound primary antibody. Subsequently, oocytes were incubated with 2 
µg/ml horseradish-coupled secondary antibody (goat anti-rat F (ab´) 2 fragments, Jackson 
ImmunoResearch) for 60 min. After incubation, oocytes were washed six times with ND96 
with 1% BSA followed by three washing steps in ND96 without BSA. Oocytes were then 
placed individually in wells of microplates and luminescence was quantified in an “Orion II 
microplate luminometer” (Berthold Detection Systems; Pforzheim). The chemiluminescent 
substrate (50 µl of Super Signal ELISA; Thermo Fisher) was added automatically and 
luminescence was measured after 2 s for 5 s. Relative light units per second (RLUs/s) were 
calculated as a measure of surface expressed channels. The results are from two 
independent experiments from two different frogs. Eight oocytes were analyzed for each 
experiment and each condition. 
 
2.2.10 Synthesis of capped cRNA 
For expression of HyNaCs in Xenopus oocytes, 5´-capped cRNA was synthesized from 
plasmid DNA by in vitro transcription with the SP6 “mMessage mMachine Kit” (Ambion). As 
template for transcription, HyNaCs cloned in the oocyte expression vector pRSSP 6009 
were used. The vector carries a SP6 polymerase-binding site 5´-upstream of its multiple 
cloning site. Synthesis of cRNA was done according to the manufactures manual. In short, 2 
µg of template DNA was linearized by restriction enzyme digest with Mlu I. The linearized 
DNA was purified from proteins and contaminations by phenol/chloroform extraction and 
then precipitated at -80°C with 550 µl 100% ethanol and 20 µl 3M NaAc. After centrifugation 
at 4 °C for 12 min, the DNA was dried in a centrifugal evaporator and resuspended in 6 µl 
DEPC H2O. The cRNA synthesis was performed with 5 µl of the purified DNA template for 2 
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hours according to the manufacturers instructions. After cRNA synthesis, the reaction-mix 
was precipitated by adding 30 µl DEPC H2O and 30 µl precipitation solution containing 7 M 
LiCl and 50 mM EGTA. The precipitated RNA was centrifuged at 4°C for 15 min to pellet the 
cRNA. The supernatant was removed, the pellet was washed with 1 ml 70% EtOH and 
again centrifuged at 4°C for 15 min. The supernatant was removed again and the cRNA 
pellet was resuspended in 20 µL DEPC H20. Finally, the concentration of cRNA was 
adjusted to ≈200 ng/µl by running samples on an agarose gel against RNA standards with 
known concentration. The cRNA was separated into aliquots and stored at -80°C. 
 
2.3 Electrophysiological methods 
2.3.1 Preparation and handling of oocytes 
Stage V to VI oocytes (Eppig and Dumont, 1974) were surgically removed from Xenopus 
leavis frogs that had been anaesthetized for 30 min in tap water containing 1% (w/w) ethyl 
3- aminobenzoate methanesulfonate salt (Sigma) prior to surgery. After anaesthetisation, 
the frog was placed on ice and a ≈1cm long cut along the body axis into the abdominal skin 
and subcutaneous musculature layer was made in order to remove a sufficient number of 
oocytes. After removal of oocytes the cuts of skin and muscle layer were stitched separately 
with absorbable yarn. Frogs were operated several fold; the interval between individual 
surgeries was at least 3 month. 
The freshly removed oocytes are agglutinated in “bags” consisting of connective tissue and 
blood vessels. To isolate single oocytes, the bags were roughly reduced to small pieces 
with forceps. Afterwards, oocytes were separated enzymatically by shaking in OR-2 
medium containing 1mg/ml collagenase type A (Sigma) for approx. 2 hours. After 
incubation, oocytes were extensively washed in OR-2 to completely remove the 
collagenase. Healthy looking oocytes were manually selected for injection. 
 
2.3.2 Injection of oocytes  
For injection of cRNA, EGTA or Fura2-AM into oocytes, pulled glass capillaries (Order ID 
4878; World Precision Instruments) were used. Capillaries were pulled with an automatic 
puller (Flaming/Brown Micropipette Puller Model P-97; Sutter Instrument Co.) in two pulling 
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steps. Before the capillaries were mounted to the microinjector, the tips were manually 
broken under a stereomicroscope to enlarge the tip diameter. Afterwards, the capillaries 
were backfilled with paraffin oil and mounted on a hand driven microinjector (Nanoliter 2000, 
World Precision Instruments). The oocytes were placed on a petri-dish containing boreholes 
to fixate the oocytes and filled with OR-2 solution The petri-dish containing the oocytes and 
the microinjector were mounted on a custom made coarse manipulator driven table to 
facilitate the injection.  
 
2.3.2.1 Concentrations and volumes used for injection  
Injection volume of cRNA was 41.6 nI. If cRNA was injected undiluted, the total amount of 
RNA per oocyte was ≈8 ng. To adjust the expression level of the individual ion channels, 
cRNA was diluted with DEPC H20, if necessary. If not stated otherwise, the following 
dilutions were used: HyNaC2/3 undiluted; HyNaC2/3/5_D-C undiluted; HaFaNaC undiluted; 
HyNaC2/3/5 1:25; for the bioluminescence assay, a total amount of ≈2.8 ng was injected for 
each condition. After injection, oocytes were incubated in OR-2 2-4 days at 19°C before 
measurements. 
To suppress the calcium activated chloride channels (CaCCs), 50 nl EGTA or BAPTA 
solution was injected 30-120 min before the experiments. EGTA solution contained (in mM): 
20 EGTA, 5 HEPES, pH was adjusted to 7.4 with NaOH. For the BAPTA solution, EGTA 
was replaced by an equimolar amount of BAPTA. 
For photometric calcium measurements, oocytes were injected with 50 nl Fura2-AM (1 mM) 
30-120 min prior to the recording. The AM ester form was used solely due to availability. 
 
2.3.3 Production of glass electrodes for the TEVC-
measurements 
As electrodes for the TEVC, borosilicate capillaries with filament (1.05 mm ID, 1.5 mm OD) 
were used. They were pulled with an automatic puller (Flaming/Brown Micropipette Puller 
Model P-97; Sutter Instrument Co.) in two pulling steps. Capillaries were filled with 3M KCl 
solution and had a resistance in the range of 0.5-1.5 MΩ.  
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2.3.4 Setup for TEVC-measurements: 
Electrophysiological recordings were performed with the software-controlled, semi-
automated OTC-20 system (npi Electronics). This system consists of a rotary table, a 
recording chamber and a control interface. The recording chamber is equipped with holders 
for fixation and movement of the two electrodes as well as adapters for the voltage and 
current grounding electrodes. It is situated above the rotary table that carries the individual 
recording solutions. During measurement, the oocyte is fixed in the chamber via suction on 
a glass electrode. Recording solutions are applied via the rotary table that can be loaded 
with up to 20 different petri-dishes. Thereby, the solution in the petri-dish situated under the 
recording chamber is, controlled by a valve, sucked into the recoding chamber. The 
turntable and the valve are controlled by the OTC-20 interface. Due to the small chamber 
volume, this setup allows the exchange of 80% solution within 300 ms (Chen et al., 2006b). 
The whole setup was made up of a TurboTec03X amplifier (npi Electronics), an 
oscilloscope HM 507 (Hameg Instruments) and a computer equipped with the AD/DA 
interface PCI 1200 (Texas Instruments). Data acquisition and control of the OTC-20 
interface was managed with the software Cellworks 6.2.2 (npi electronic).  
 
2.3.5 Solutions used for TEVC-measurements  
OR-2 solution (Oocyte ringer solution 2):  
NaCl  82.5 mM 
KCl  2.5 mM 
Na2HPO4  1 mM 
Polyvinylpyrroldione (PVP) 0.5 g/l 
MgCl2  1 mM 
CaCl2  1 mM 
HEPES  5 mM 
  pH: 7.3; adjusted with 1M NaOH 
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Standard bath solution:  
NaCl  1mM 
CaCl2  1mM  
HEPES  10 mM 
  pH: 7.4; adjusted with 1 M NaOH 
 
2.3.6 Analysis of electrophysiological data 
Data were recorded with the software Cellworks 6.2.2 (npi Electronics) with a sampling 
frequency of 0.1-1kHz, filtered at 20 Hz and stored on hard drive. Analysis of data was done 
either using Cellworks or the software IgorPro 6.02 (Wave Metrics). Statistical analysis and 
determination of significance was done with Excel for Mac 12.3.2. (Microsoft) using 
Student´s paired or unpaired t-test, as appropriate. Figures were created using the software 
Canvas 10.6.8 (ACD Systems).  
If not stated otherwise, voltage was clamped at -70 mV and measurements were performed 
at room temperature (20-25°C). 
Results are reported as means ± SEM unless stated otherwise. They represent the mean of 
n individual measurements on different oocytes.  
Concentration response curves were determined by fitting data to the Hill function (Hill, 
1910): 
(1) 
 
Where Imax is the maximal current, a is the residual current, [c] is the concentration of the 
ligand, EC50 is the concentration at which half maximal activation occurs and n is the Hill 
coefficient. 
For determination of reversal potentials Erev, all current-voltage relationships were corrected 
for background conductivities by subtracting the currents measured at a given voltage 
without agonist application. For calculation of reversal potentials and calculation of relative 
permeabilities (in Figs. 23; 24D; 25A and B), oocytes were additionally injected with EGTA 
(20 mM) to minimize the influence of CaCCs. All I-V relationships were corrected for 
€ 
I = a + Imax − a( )1+ (EC50 /[c])n[ ]
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background conductances by subtracting the currents measured without agonist 
application. 
Ionic permeability ratio for monovalent cations PNa/PK (see 3.2.3) was calculated from the 
shift in Erev when NaCl in the standard bath solution was replaced by an equimolar amount 
of KCl, according to the following equation derived from the Goldman-Hodgkin-Katz 
equation (Hille, 2001): 
 
 
(2) 
 
 
Where ∆ Erev = ENa - EK, R is the gas constant, F is the Faraday constant, and T is the 
temperature. It was assumed that the intracellular concentrations of Na+ and K+ are 
constant within one batch of oocytes. 
Assuming additionally that [Ca2+] is very small, PCa/PNa can be calculated from the shift in 
Erev when Na+ჼ was replaced by Ca2+ in the application solution, according to the following 
equation (Lewis, 1979; Bässler et al., 2001): 
 
 
 
(3) 
 
 
Where ∆ Erev = ENa– ECa; R, T and F have the same meaning as above. The solution used to 
determine ECa contained (in mM): CaCl2 10, NMDG-Cl 126.5, HEPES 10, pH 7.4; the 
solution used to determine ENa contained: NaCl 140, CaCl2 1, HEPES 10, pH 7.4. The minor 
amount of Ca2+ in this solution was considered negligible.  
Activity of ions was used in all terms of [c]. Activity coefficients fi of single ions i of valence z 
were calculated for Na+ჼ and Ca2+ჼ with a modified Davies equation (Davies, 1962; Bässler 
et al., 2001):  
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Where I is the ionic strength, which is defined as (Bässler et al., 2001):   
 
 I = 0.5 Σ  ci zi2 (5) 
 
In all figures of this work showing voltage ramps and in the bioluminescence assay, the 
individual conditions were were measured with different oocytes of the same batch (except 
measurements for the P2X4 receptor  in Fig. 23B, which were performed on separate 
batches of oocytes). Furthermore, batches of oocytes were identical between Fig. 21 and 
Fig. 24D and between Fig. 23A and Fig. 25A. 
 
2.4 Photometric calcium measurements 
Oocytes were injected with 50 nl Fura2-AM (1 mM) 30-120 min prior to the recording and 
were placed with the animal pole facing away from the objective on a 35mm petri dish that 
was filled with 4.5 ml standard bath solution and had a drilled hole to fixate the oocyte. 
Measurements used a BX51WI upright microscope (Olympus) with a 40x water immersion 
objective (NA 0.8) and a TILL photometry system (TILL Photonics, Gräfelfing, Germany). 
The region of interest chosen for recording included most of the upper surface of the cell. 
The penetration depth of the optics into the oocyte was unknown but is estimated not to be 
more than a few micrometers. Fura-2 was excited every 2 seconds with a 100 ms pulse of 
340 nm light and a 50 ms pulse of 380 nm light using a Polychrome 5 light source (TILL 
Photonics). Emission was collected by a Photodiode (TILL Photonics) behind a 535/30 nm 
bandpass filter, digitized at 5 kHz by a LIH8+8 interface run by Patchmaster software 
(HEKA, Lambrecht, Germany). Emission during the 340 nm pulse and the 380 nm pulse 
was averaged and the F340/F380 ratio determined for each time point (emission with 340 
nm excitation / emission with 380 nm excitation). As emission was generally lower with 340 
nm than with 380 nm excitation, a longer recording was taken for the 340 nm excitation to 
increase the signal-to-noise-ratio. Currents were recorded simultaneously with a 
TurboTec03X amplifier (npi Electronics) filtered at 20 Hz and digitized at 100Hz also using 
the LiH8+8 interface and Patchmaster software. To activate HyNaCs, 500 µl HydraRFamide 
I (10µM) was manually applied to the petri dish to achieve a final concentration of ≈1 µM. 
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Data were analyzed offline using IGOR Pro (WaveMetrics, Lake Oswego, USA). The 
fluorescence changes induced by HyNaC agonists were reproducible and large compared 
to the signal-to-noise-ratio (Fig. 22A). On average, they were 47 ± 9 % of baseline 
F340/F380 ratio and small compared to the variation between cells in resting F340/F480 
ratio (Fig. 22B). Therefore no calibration and conversion of the F340/380 signal into 
absolute intracellular concentrations of Ca2+ could be performed.  
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III. Results 
3.1 Part I - Three homologous subunits form a high 
affinity peptide-gated ion channel in Hydra 
3.1.3 Aims of the first study  
The diverse physiological roles and gating mechanisms of DEG/ENaCs raise the question 
of the primordial functions of these channels in their common ancestor. Which features 
arose early in evolution and can be considered as basic and evolutionary conserved and 
which features developed later and are only found in individual subgroups of the channel 
family? This question can be addressed by comparative analysis of DEG/ENaCs from 
evolutionary separated groups of animals. Animals from the phylum Cnidaria are especially 
suited to answer this question, as they are the most basic group in which a nervous system 
has evolved. Hydra magnipapillata belongs to the phylum Cnidaria and is an important 
model organism for the evolution of the nervous system and developmental processes. 
Therefore, our group has cloned new DEG/ENaC members from Hydra and named them 
HyNaCs (Hydra sodium channels). It was already shown in a previous study that HyNaC2 
and 3 together form an ion channel directly gated by endogenous neuropeptides (Golubovic 
et al., 2007; 2007) . 
The aim of the first part of this thesis was the characterisation of HyNaC5, a novel 
DEG/ENaC subunit from Hydra. Therefore, HyNaC5 was heterologously expressed in 
Xenopus oocytes to identify possible ligands, interaction partners and current 
characteristics of the novel subunit by TEVC-recordings. Moreover, the specific expression 
pattern of HyNaC5 in Hydra was revealed with an in situ hybridisation assay. Finally, in a 
behavioural assay, we attempted to figure out putative physiological functions of HyNaCs in 
the living animal.  
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3.1.3 Cloning of HyNaC5 from Hydra magnipapillata 
A new partial sequence with high homology to HyNaC2-4 from Hydra magnipapillata was 
identified by screening an on-line Hydra Expressed Sequence Tag data base and used to 
design primers for rapid amplification of 5´ and 3´-cDNA ends (RACE). From these 5´- and 
3´-RACE products, a new full-length cDNA was cloned in our group by Stefan Gründer. The 
corresponding protein was named HyNaC5 and was kindly provided for further 
characterisation (see Appendix for methods). The predicted amino acid sequence of 
HyNaC5 is shown together with the sequences of HyNaC2–4 in Fig. 10A. 
 
The degree of amino acid sequence identities between HyNaC5 and HyNaC2–4 ranges 
from 28–44%; the closest relative is HyNaC2 (Fig. 10B). Thus, sequence identities between 
different HyNaCs are similar to sequence identities between the three subunits of the 
 
Fig. 10: (A) Sequence alignment of HyNaC5 with HyNaC2–4. Amino acids showing a high degree of identity are 
shown as white letters on a black background. The putative positions of transmembrane domains are indicated 
by bars, conserved cysteines are indicated by circles, and consensus sequences for N-linked glycosylation in 
HyNaC5 are indicated by branched symbols. Accession numbers are as follows: HyNaC2, AM393878; HyNaC3, 
AM393880; HyNaC4, AM393881; and HyNaC5, FN257513. (B) Phylogram illustrating the relationship of 
HyNaCs. Amino acid sequences of HyNaC2–5 and rat BLINaC were aligned, and the tree for the phylogram was 
established by Neighbor Joining with ClustalX; highly divergent sequences at the N- and C-termini had been 
deleted. Branch lengths are proportional to the evolutionary distance. BLINaC is a related channel (Golubovic et 
al., 2007) that was included for comparison; the accession number of rat BLINaC is Y19034. 
(From: Dürrnagel et al., 2010) 
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epithelial Na+ channel, ENaC (Canessa et al., 1994). The open reading frame of the 
HyNaC5 cDNA codes for a protein of 473 amino acids with a predicted molecular mass of 
≈55 kDa. HyNaC5 shows the structural hallmarks of the DEG/ENaC gene family: two 
hydrophobic transmembrane domains, short N- and C-termini, and a large extracellular loop 
containing 12 conserved cysteines between the two hydrophobic domains (Fig. 2). A 
topology with two transmembrane domains, a large ectodomain, and short intracellular 
termini is common to all DEG/ENaC subunits (Jasti et al., 2007). 
 
3.1.3 Expression pattern of HyNaC5 
To investigate the expression pattern of hynac5 in Hydra, a 1435 bp fragment from the 
coding part of HyNaC5 cDNA was cloned into the vector pBluescriptKS and used as probe 
for whole mount in situ hybridization (ISH). The ISH was carried out by Anne Kuhn in the lab 
of T.W. Holstein, Heidelberg, Germany (see Appendix for methods). It revealed strong 
expression of hynac5 at the base of the tentacles (Fig. 11A), most likely in 
epitheliomuscular cells. During budding, hynac5 is expressed at the sites of tentacle 
formation, immediately before the first tentacle bumps appear (Fig. 11G). Thus, the 
expression pattern of hynac5 is very similar to the expression patterns of hynac2 and 
hynac3 (Fig. 11) (Golubovic et al., 2007), suggesting that the three genes are coexpressed 
in Hydra cells.  
A more careful comparison, however, reveals subtle differences in the expression pattern of 
the three genes. Although hynac2 and hynac3 are uniformly expressed at the tentacle base 
(Fig. 11, B and C), hynac5 expression is strongest at the oral site of each tentacle base with 
a gradient toward the aboral site (Fig. 11 and Fig. 12A). 
Results 
46 
By comparison, hynac4 expression exhibits a strong restriction to the aboral site of the 
tentacles (Fig. 12B) (Golubovic et al., 2007). The mutually exclusive expression patterns of 
hynac4 and hynac5 at the base of the tentacles suggest a different function for HyNaC4 and 
HyNaC5. Previously, it was speculated that activation of HyNaCs leads to tentacle 
contractions during the “feeding reaction” of Hydra (Golubovic et al., 2007). The feeding 
reaction is induced by physical contact with a prey animal and characterized by an upward 
movement and contraction of the tentacles, which brings the prey close to the mouth 
(Loomis, 1955). Perhaps HyNaC4 and HyNaC5 have distinct roles in the coordination of this 
feeding behavior.  
 
Fig. 11: hynac5 is expressed at the base of the tentacles. Whole mount in situ hybridization reveals strong 
expression of hynac5 transcripts at the tentacle base in adult animals (A) and buds (D and G). By comparison, 
hynac2 and hynac3 transcripts are uniformly distributed (B and C). During bud formation, hynac5 transcripts 
appear as soon as tentacles begin to appear (G) similar to hynac2 and hynac3 (E and F, and H and I). 
Expression of hynac5 is strongest at the upper side (oral) of the tentacles (A); primary magnifications are 4 ×  
(A–C) and 20 ×  (D-I). 
(From: Dürrnagel et al., 2010) 
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3.1.3 HyNaC5 strongly increases the current amplitude of the 
HyNaC2/3/5 heteromer 
The functional properties of HyNaC5 were investigated by expression in Xenopus oocytes; 
cRNAs coding for HyNaC2–5 were injected in oocytes either alone or in combination. 
Oocytes expressing HyNaC5 alone or in combination with one other HyNaC subunit (2, 3, or 
4) could not be activated by any of the four HydraRFamides (I–IV; data not shown). In 
contrast and as previously reported (Golubovic et al., 2007), oocytes coexpressing HyNaC2 
and -3 exhibited a robust current after stimulation with HydraRFamide I (Fig. 13A) and II 
(data not shown); current amplitudes were usually in the range of a few µA. Oocytes 
expressing HyNaC5 in addition to HyNaC2 and -3 could also be activated by RFamides I 
and II and showed dramatically increased current amplitudes compared with oocytes 
coexpressing only HyNaC2 and -3: current amplitudes of oocytes expressing HyNaC2, -3, 
and -5 were so large (<50 µA) that they were above the capacity of the used TEVC-amplifier 
 
Fig. 12: hynac5 and hynac4 show complementary expression patterns. hynac5 is expressed at the oral site of 
the tentacle bases (A) and in early bud (C), whereas hynac4 is expressed at the aboral site of the tentacles (B); 
it also lacks any expression in early bud stages. Arrows indicate the different expression zones of both genes; 
primary magnifications are 20 ×  (A–C). 
(From: Dürrnagel et al. 2010) 
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(Fig. 13A, left panel). A quantitative comparison with oocytes, which had been injected with 
25-fold diluted RNA, and half-maximal peptide concentrations (see below) revealed a 16-
fold increase in the peak current amplitude of HyNaC2/3/5 compared with HyNaC2/3 (p ≤ 
0.01; Fig. 13A, right panel), strongly suggesting that HyNaC5 was incorporated in the 
channel complex to form a HyNaC2/3/5 heteromer.  
 
 
Fig. 13: (A) HyNaC5 potently increases the current amplitude of the HyNaC2/3 heteromer. Left, bar graphs 
illustrating the whole oocyte current amplitude after coexpression of different combinations of HyNaC subunits; 
HyNaCs were activated with 30 µM HydraRFamide I. For each condition, a total of ≈8 ng cRNA had been 
injected in oocytes. Note that the amplitude for HyNaC2/3/5 was > 50 µA and therefore only a lower limit of the 
amplitude can be given. Error bars represent S.E.; for HyNaC2/3/5, the S.E. could not be calculated. n =10 
oocytes. Right, bar graphs illustrating current amplitude of oocytes coexpressing HyNaC2/3 or HyNaC2/3/5; a 
total of ≈0.3 ng cRNA had been injected. Both channels were activated with a concentration of HydraRFamide II 
eliciting half-maximal response: HyNaC2/3 with 33 µM and HyNaC2/3/5 with 0.35 µM. ***, p ≤ 0.001. (B) 
representative current traces for the HyNaC2/3/5 heteromer. Repeated activation of HyNaC2/3/5 with Hydra- 
RFamides led to decreased response between the first and second application; in the example shown, 30 µM 
HydraRFamide I was used. cRNA for HyNaCs 2, 3, and 5 was diluted 25-fold (a total of 0.3 ng/oocyte). (C) 
HyNaC5 does not increase surface expression of the HyNaC2/3 heteromer. Surface expression of HyNaC2 and 
HyNaC2/3 in comparison to HyNaC2/3/5 (mean ± S.E.); only the HyNaC2 subunit was HA-tagged. Oocytes 
injected with untagged HyNaC2/3/5 served as a control (first column). The results are expressed as relative light 
units (RLUs)/oocyte/s (n = 16). **, p ≤ 0.01. 
(From: Dürrnagel et al., 2010) 
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The crystal structure of an ASIC1 - a related acid-sensing ion channel - revealed a number 
of three subunits in the functional channel (Gonzales et al., 2009; Baconguis and Gouaux, 
2012). Because acid-sensing ion channels are close relatives of HyNaCs in the DEG/ENaC 
gene family (Golubovic et al., 2007), it is reasonable to assume that functional HyNaCs are 
also composed of three subunits, suggesting a 1:1:1 ratio for the HyNaC2, -3, and -5 
subunits in the functional complex.  
In the remainder of this study, 25-fold diluted cRNAs of HyNaC2/3/5 were usually injected to 
get current amplitudes in the range of 1–30 µA. Oocytes coexpressing HyNaC5 together 
with HyNaC2 and -4 could also be activated by HydraRFamides I and II; current amplitudes 
were much smaller than for the HyNaC2/3/5 heteromer, however (Fig. 13A), suggesting that 
although HyNaC4 is closely related to HyNaC3 (Fig. 10B) it cannot efficiently replace it in 
the heteromeric complex. Fig. 13B shows representative current traces of oocytes 
expressing HyNaC2, -3, and 5. Similar to HyNaC2/3 channels (Golubovic et al., 2007), 
HyNaC2/3/5 currents exhibited a biphasic morphology when measured in Xenopus oocytes: 
A rapid declining peak amplitude was followed by a sustained current. A second application 
of the ligand induced currents with significantly smaller amplitudes than the first application. 
Further applications of the ligand induced currents with amplitudes comparable with the 
second application. In previous reports, this current characteristic was stated as an intrinsic 
property of HyNaC channels (Golubovic et al., 2007; Dürrnagel et al., 2010). However, 
these conclusions were wrong. HyNaC 2/3/5 and most likely also HyNaC 2/3 are highly 
permeable for Ca2+ (see 3.2 and Discussion). The influx of Ca2+ through HyNaCs leads to 
strong activation of Ca2+ activated chloride channels (CaCCs), which are endogenously 
expressed in Xenopus oocytes. Therefore, all current traces shown in the first part of the 
results are the sum of two current components: The HyNaC current and the current that 
rises from secondary activation of CaCCs. When CaCCs are blocked by injection of the 
Ca2+ chelators EGTA or BAPTA, the simple, step-like, non-desensitizing current 
characteristic of HyNaC2/3/5 is revealed (Fig. 19). The reduction of current amplitudes after 
repeated activation is mediated by run-down of CaCC currents. 
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3.1.3 HyNaC5 strongly increases the current through surface-
expressed HyNaCs	  	  
Increased current amplitudes of the HyNaC2/3/5 heteromer compared with the HyNaC2/3 
heteromer (Fig. 13A) can be due to increased surface expression and/or increased current 
through surface-expressed channels. To differentiate between these possibilities, the 
expression level of the two heteromers at the oocyte surface was compared. Therefore an 
HA-epitope was inserted into the extracellular loop of HyNaC2 and by use of a monoclonal 
anti-HA antibody and a luminescence assay the surface expression of HA-tagged channels 
was compared (Chen and Gründer, 2007). Luminescence was not significantly different (p = 
0.3) between oocytes expressing the HyNaC2/3/5 heteromer and oocytes expressing the 
HyNaC2/3 heteromer (Fig. 13C). For oocytes expressing the heteromers, luminescence 
was, however, significantly larger than for oocytes expressing HyNaC2-HA alone (p ≤ 0.01), 
for which luminescence was not significantly above background (p = 0.2; Fig. 13C). 
Assuming a number of three subunits in a functional HyNaC (Gonzales et al., 2009), in the 
2/3/5 channel only one subunit per channel was tagged, whereas in the 2/3 channel either 
one or two subunits were tagged, depending on the subunit stoichiometry (2/3/3 or 2/2/3). 
Therefore, in the case of a 2/2/3 channel, the assay would underestimate the surface 
expression of the 2/3/5 channel relative to the 2/2/3 channel by a factor of two. Even in this 
case, however, the difference in surface expression (at most 2-fold) cannot account for the 
16-fold difference in current amplitude (Fig. 13A). Thus, HyNaC5 predominantly increases 
the current through surface-expressed channels. This result suggests that the HyNaC2/3 
heteromer either has a small single channel amplitude or that HydraRFamides are partial 
agonists at this channel, leading to a low open probability. 
 
3.1.3 HyNaC5 changes the properties of the HyNaC2/3 
heteromer 
Similar to HyNaC2/3, HyNaC2/3/5 was activated by HydraRFamides I and II. For both 
peptides, the affinity of HyNaC2/3/5 was increased ≈100-fold compared with HyNaC2/3 
(Fig. 14): half-maximal activation was obtained with 4.8 ± 2.0 µM (n = 8) HydraRFamide I 
and 0.34 ± 0.08 µM (n = 8) HydraRFamide II compared with 326 ± 108 µM and 38 ± 13 µM 
(n = 4, each), respectively, for HyNaC2/3. In each case, the concentration response curve 
could be well fitted assuming a single population of channels, suggesting that most of the 
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channels in oocytes coexpressing HyNaC2, -3, and -5 were of a single type (2/3/5). Hill 
coefficients were similar for HyNaC2/3/5 and HyNaC2/3 (0.9 ± 0.1 compared with 0.8 ± 0.1 
for HydraRFamide I, p = 0.6, and 1.8 ± 0.2 compared with 1.7 ± 0.4 for HydraRFamide II, p 
= 0.8, respectively; n = 8 for HyNaC 2/3/5 and n = 4 for HyNaC 2/3). 
It is important to mention that the apparent affinities were measured without block of 
secondary activated CaCCs. Therefore, the EC50 values and Hill coefficients should be 
considered as rough estimate. However, concentration response curves recorded for 
HyNaC2/3/5 that had been injected with EGTA to block contaminating CaCC currents 
yielded comparable EC50 values (Marc Assmann, personal communication). 
Previous evidence suggested that HydraRFamides activate HyNaC2/3 directly and not by a 
second messenger cascade (Golubovic et al., 2007). Activation of HyNaC2/3/5 with a 
strongly increased affinity for HydraRFamides further confirms that the binding sites for 
HydraRFamides are on HyNaCs and that these peptides directly activate HyNaCs. In 
 
Fig. 14: HyNaC5 strongly increases apparent affinity for HydraRFamides. Top, representative current traces 
of whole oocytes either expressing HyNaC2 and -3 or HyNaC2, -3, and -5; channels were activated with 
HydraRFamide I. Bottom, concentration-response curves for HyNaC2/3 (open symbols) and HyNaC2/3/5 
(closed symbols), each with HydraRFamides I (circles) and II (squares). Error bars represent S.E., and lines 
were fitted to the Hill function. Current amplitudes were normalized to the amplitude obtained with the highest 
concentration of the ligand (Imax) (n = 8 for HyNaC2/3/5 and n = 4 for HyNaC 2/3). 
(From: Dürrnagel et al., 2010) 
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oocytes expressing the HyNaC2/3/5 heteromer (dilution, 1:25), high concentrations (50 µM) 
of HydraRFamides III and IV also elicited a tiny current (≈0.1 µA; data not shown), 
suggesting that these peptides are agonists at this channel with a very low affinity. 
HydraRFamides III and IV did not activate other subunit combinations, also containing 
HyNaC4. One might speculate that a related channel, perhaps containing HyNaC4 in 
combination with other HyNaC subunits not yet identified, is the high affinity receptor for 
HydraRFamides III and IV.  
Reversal potentials in standard bath solution were not significantly different between 
HyNaC2/3/5 and HyNaC2/3 (10.1 ± 1.2 mV compared with 8.6 ± 3.5 mV; n = 8; p = 0.69; 
Fig. 15A), indicating that both HyNaC2/3 and HyNaC 2/3/5 are unselective channels. The 
inward rectification of HyNaC2/3/5 suggests that for HyNaC2/3/5 outward K+ currents are 
less well conducted than for HyNaC2/3.  
However, due to secondary activation of CaCCs in consequence of the Ca2+ permeability of 
HyNaC2/3/5 and HyNaC2/3 channels, the reversal potentials are likely contaminated by 
chloride currents. Assuming an intracellular concentration of 33 mM intracellular chloride 
(Barish, 1983), the calculated equilibrium potential of chloride in standard bath solution is  ≈ 
-38 mV. This would cause an artificial leftward shift of reversal potentials. Therefore, a more 
precise measurement of PNa+/PK+ values of HyNaC 2/3/5 is given in chapter 3.2.3.  
To further investigate the ion permeability, all extracellular Na+ was replaced by Li+ or K+ 
and the current amplitude of inward currents at –70 mV was measured. In the case of 
HyNaC2/3/5, inward currents with K+ and Li+ as the main charge carrier were significantly 
smaller than Na+ currents (p < 0.01; Fig. 15B). This relative current reduction was especially 
prominent for K+ and indicates that HyNaC2/3/5 is more selective for Na+ over K+ and Li+ 
than HyNaC2/3. In the case of HyNaC2/3, amplitudes of inward K+ and Li+ currents were 
also significantly smaller than Na+ currents, but the reduction in relative amplitude was 
smaller than for HyNaC2/3/5 (p < 0.01; Fig. 15B). Together, these results show that the ion 
pore of HyNaC2/3/5 has slightly different permeability properties than the HyNaC2/3 pore.  
In addition to a low selectivity for Na+, the HyNaC2/3 pore is characterized by a low 
apparent affinity for the open channel blocker amiloride (Golubovic et al., 2007), which is 
also uncommon for DEG/ENaC channels. 
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 According to previous findings, it was confirmed that for HyNaC2/3 the IC50 for amiloride is 
≈500 µM (540 ± 160 µM; n = 5; Fig. 16A). In contrast, for HyNaC2/3/5 the IC50 for amiloride 
was significantly reduced (122 ± 9 µM; p < 0.02; n = 6; Fig. 16A). As FaNaC is not only 
activated but also blocked by its peptide ligand, FMRFamide (Green and Cottrell, 1999), it 
was tested whether the low apparent amiloride affinity of HyNaCs might be due to a 
competition with HydraRFamides at the rather high peptide concentrations (30 µM) used to 
determine amiloride affinity. However, even with a 100-fold lower concentration of the 
 
Fig. 15: Ion selectivity of HyNaC2/3/5. (A) the HyNaC5 subunit does not change reversal potentials. Channels 
were activated with 30 µM (HyNaC2/3) or 0.3 µM HydraRFamide I (HyNaC2/3/5), respectively, and reversal 
potentials measured by stepping to the indicated holding potentials for 3 s. (B) the HyNaC5 subunit decreases 
currents carried by K+. Left, representative current traces of whole oocytes either expressing HyNaC2 and -3 or 
HyNaC2, -3, and -5. Channels were activated in the presence of different monovalent cations. Right, bar graphs 
illustrating the amplitude of the Li+ and K+ current relative to the Na+ current; black bars represent HyNaC2/3/5, 
white bars HyNaC2/3. Error bars represent S.E. (12 oocytes); HyNaCs were activated with 30 µM (HyNaC2/3) or 
0.3 µM HydraRFamide I (HyNaC2/3/5), respectively. In the presence of HyNaC5, amplitudes of Li+ and K+ 
currents were significantly reduced relative to the amplitude of the Na+ current. **, p < 0.01; ***, p < 0.001, two-
tailed t test. 
(From: Dürrnagel et al., 2010) 
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peptide (0.3 µM), apparent amiloride affinity of HyNaC2/3/5 was not significantly increased 
(IC50 = 98 ± 18 µM; p = 0.2; n = 6; Fig. 16A), showing that HydraRFamides do not strongly 
compete with amiloride. Of note, at low concentrations (1 µM) amiloride slightly increased 
HyNaC current amplitudes. 
 
An increased open probability by amiloride has previously also been noted for FaNaC 
(Jeziorski et al., 2000; Green and Cottrell, 2002). Finally, the inhibition of HyNaC2/3 and 
 
Fig. 16: HyNaC5 increases the apparent affinity for amiloride and amiloride analogs. (A), concentration response 
curve for the inhibition of HyNaC currents by amiloride. Curves were determined with 0.3 µM (HyNaC2/3/5) and 
30 µM HydraRFamide II (HyNaC2/3 and HyNaC2/3/5), respectively (n = five oocytes for HyNaC2/3 and n = 6 
oocytes for HyNaC2/3/5). (B), left, representative current traces of oocytes either expressing HyNaC2 and -3 or 
HyNaC2, -3, and -5. Channels were activated in the presence of different blockers (100 µM). Right, bar graphs 
illustrating the current remaining in the presence of the respective blockers; black bars represent HyNaC2/3/5, 
white bars HyNaC2/3. Before and after application of the blockers, channels were activated without blockers; the 
mean value of these two measurements was used to normalize the currents obtained in the presence of the 
blockers. Error bars represent S.E. (six oocytes); HyNaCs were activated with 30 µM (HyNaC2/3) or 1 µM  
HydraRFamide I (HyNaC2/3/5), respectively. In the presence of HyNaC5, amiloride (Amil) and benzamil (Benza) 
blocked significantly more current, suggesting an increased affinity for these blockers. *, p < 0.05; ***, p < 0.001, 
two-tailed t test. Phena, phenamil. 
(Adapted from: Dürrnagel et al., 2010) 
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HyNaC2/3/5 by 100 µM of the two amiloride analogs benzamil and phenamil was 
investigated. Both blockers more potently blocked HyNaC2/3/5 than HyNaC2/3 (p < 0.05; 
Fig. 16B). This increased apparent affinity was highly significant for benzamil, for which 100 
µM blocked almost 90% of the current. The increased apparent affinity for open channel 
blockers further support the conclusion that HyNaC5 is incorporated into the HyNaC2/3 
channel complex and contributes to its ion pore.  
 
3.1.3 Amiloride delays the feeding reaction of Hydra 
In situ hybridization suggested that HyNaCs might contribute to the feeding reaction of 
Hydra. We tried to support this hypothesis by investigating the feeding reaction in the 
presence of amiloride in the medium. This experiment was carried out in collaboration with 
C. D. Tsiairis in the lab of T. W. Holstein, Heidelberg, Germany (see Appendix for methods).  
The feeding reaction can be induced by glutathione (Loomis, 1955). After addition of 
glutathione (10 µM final concentration), Hydras responded quickly by moving their tentacles, 
contracting them, and bringing them to their mouth.  
When the animals were in a medium containing 100 µM amiloride, however, the initiation of 
tentacles movement was significantly delayed (p < 0.05; Fig. 17). Moreover, the movements 
 
Fig. 17: Amiloride delays the glutathione induced feeding response. H. magnipapillata were relaxed in plain 
medium or medium containing 100 µM amiloride. At time 0, glutathione was added to a final concentration of 10 
µM. Every 30 s, the number of animals moving their tentacles was recorded. A statistically significant delay in 
the response to glutathione (GSH) was detected in the presence of amiloride. The calculated p value is < 0.05 
as indicated (by an asterisk), whereas it is 0.06 for the time point 1:00. 
(From: Dürrnagel et al., 2010) 
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did not lead to the characteristic contraction of the tentacles pointing them to the mouth. 
Similarly, the natural catching reaction after exposing Hydra to Artemia shrimps was 
inhibited by 100 mM amiloride (data not shown). These effects of amiloride were reversible; 
when animals were brought back to a medium without amiloride, they could feed on Artemia 
like the untreated ones and responded properly to glutathione by initiating the feeding 
reaction. Amiloride did not affect the general behavior of the animal; animals were still able 
to contract and move in the medium. However, they were unable to perform the coordinated 
movements of the tentacles associated with feeding reflex, suggesting the potential 
importance of amiloride-sensitive ion channels for the feeding reaction.  
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3.2 Part II - High Ca2+ permeability of a peptide-gated 
DEG/ENaC from Hydra  
3.2.3 Aims of the second study 
The aim of the first part of this work was the basic characterisation of HyNaC5. It was 
shown that coexpression of HyNaC2, -3 and -5 forms an ion channel that is directly gated 
by HydraRFamides and has different properties than the channel made of HyNaC2 and -3. 
HyNaC2/3 or 2/3/5 expressing oocytes exhibit a biphasic current consisting of a transient 
peak and a sustained component. In the first part of this work and in a previous study 
(Golubovic et al., 2007) the measured currents were entirely attributed to currents passing 
through the HyNaC pore. However, this assumption was wrong. HyNaC2/3/5 is permeable 
for Ca2+ and this Ca2+ influx through HyNaCs activates CaCCs, which are endogenously 
expressed in Xenopus oocytes. Therefore, the measured currents consist of a HyNaC and a 
CaCC fraction. This finding is surprising, as all known DEG/ENaC channels are Na+ 
selective and Ca2+ impermeable or conduct Ca2+ only to a minor extend. Therefore, this 
unique feature of HyNaCs was investigated in detail in the second part of this work. One 
main focus was to quantify the relative Ca2+ permeability and to compare it to other known 
Ca2+ permeable channels. Furthermore, the contaminating Cl- currents in previous 
measurements demanded re-evaluation of some basic properties of HyNaC2/3/5 when 
CaCCs were blocked. Finally, we aimed to identify conserved amino acids that are crucial 
for the high Ca2+ permeability of HyNaC2/3/5. 
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3.2.3 The transient current in HyNaC-expressing oocytes is 
carried by Cl- 
Fig. 18A illustrates the typical biphasic currents elicited by HydraRFamide I (Moosler et al., 
1996) in oocytes expressing HyNaC2/3/5 (named HyNaC in the remainder of the results, for 
simplicity). A fast transient current was followed by a slower sustained current; the ratio of 
transient and sustained currents was variable. Typically, a second peptide application 
elicited a similar response but of smaller amplitude (72 ± 8% of the first amplitude, n = 11, p 
< 0.01; Fig. 18A and Fig. 19A). A third application elicited a response of similar amplitude 
as the second (74 ± 9% of the first amplitude, n = 11, p < 0.01; Fig. 18A and Fig. 19A). The 
basis for this inactivation between first and second application has remained unclear. 
In the first part of the results, Erev of the sustained current was determined by stepping to 
different voltages during long agonist applications (Fig. 15A); Erev was around +10 mV, 
indicating a relatively unselective cation current. Now, Erev of the peptide-activated currents 
was determined by repeatedly activating HyNaC at different holding potentials between -70 
and +20 mV. Notably, the transient and sustained components had different Erevs (Fig. 18B 
and C). While at -20 mV the transient current was clearly outward, the sustained current 
was inward, showing that both currents had different ion selectivity. Although the strong 
rectification rendered a precise determination of Erev of the sustained current difficult, it was 
estimated to be 2 ± 3 mV (n = 6; Fig. 18C), similar to the results in Fig. 15B. In contrast, Erev 
of the transient current was -22 ± 2 mV (n = 6; Fig. 18C). Thus, the transient current clearly 
had different ion selectivity than the sustained current (p < 0.001). The leftward shift of the 
reversal potential, however, was not compatible with an increased Na+-selectivity of the 
transient current. In addition, it is notable that at more depolarized potentials the amplitude 
of the transient outward current decreased rather than increased in amplitude (Fig. 18B and 
C). This decreased amplitude can now be attributed to a block by Ca2+ that inhibits flux of 
ions at more depolarized potentials (see below).  
Assuming an intracellular Cl- concentration of 33 mM, as reported for immature oocytes 
(Barish, 1983), in standard bath solution the Cl- equilibrium potential was -38 mV, close to 
Erev of the transient current. Therefore it was tested, whether Cl- contributed to the transient 
current and Erev was determined in Cl--free solutions. Under these conditions, outward 
currents due to influx of Cl- were abolished (Fig. 18D). While Erev of the sustained current 
was not changed (Erev = 0.6 ± 2.8 mV, n = 5, p = 0.8), no transient outward currents were 
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observed, strongly suggesting that the transient outward current in Cl--containing solutions 
was carried by Cl-. 
Xenopus oocytes contain a Ca2+-activated Cl- channel (CaCC) in their plasma membrane, 
which is activated by increases in intracellular Ca2+ concentration (Miledi, 1982; Barish, 
1983). Activation of the CaCC leads to biphasic currents: an initial transient Cl- current 
(Miledi, 1982; Barish, 1983; White and Aylwin, 1990) is followed by sustained Cl- currents 
(Boton et al., 1990; Wu and Hamill, 1992; Schroeder et al., 2008), resembling the 
appearance of peptide-activated currents in HyNaC expressing oocytes. Moreover, 
repeated activation of the CaCC leads to reduced responses (Boton et al., 1990; Wu and 
 
Fig. 18: Transient peptide-activated currents depend on Cl-. (A) Representative current trace showing activation 
of HyNaC2/3/5 in standard bath. HyNaC was activated with 1 µM HydraRFamide I (black bars). (B) Repeated 
activation of HyNaC at different holding potentials (Vhold) reveals the different reversal potentials of the transient 
and the sustained current component. A representative current trace in standard bath solution is shown. Note 
that the transient current changes to outward at more negative potentials than the sustained current. The inset 
highlights the three current phases (initial inward, transient outward, sustained inward) at a holding potential of -
20 mV. (C) I/V plot revealing the different reversal potentials of the transient (open squares) and sustained 
current components (filled squares) in standard bath (n = 6). Note the strong inward rectification of both 
components. The inset shows the I/V relations close to the reversal potentials on an expanded scale. (D) 
Representative current trace in bath solution lacking Cl- (NaCl replaced by NaGluconate). Note the absence of 
transient outward currents. 
(From: Dürrnagel et al., 2012) 
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Hamill, 1992), akin to the reduced amplitude of peptide-activated currents with repeated 
peptide application (Fig. 18A and Fig. 19A). It was therefore considered that HyNaC is 
permeable to Ca2+ and that HyNaC activated the CaCC of oocytes. Closer inspection of 
measurements at a holding potential slightly positive to the Cl- equilibrium potential (-20 mV) 
indeed revealed a current with three phases (Fig. 18B, inset): an initial inward current, 
which could reflect an initial influx of cations through HyNaCs, was followed by a transient 
outward current, presumably carried by the influx of Cl-, and a third sustained inward 
current, again dominated by influx of cations through HyNaCs.  
 
3.2.3 The transient current is mediated by the endogenous 
Ca2+-activated Cl--channel.  
To test for the activation of the CaCC, oocytes were injected with either EGTA or BAPTA to 
chelate Ca2+ and prevent a rise in intracellular [Ca2+] and activation of the CaCC. Under 
these conditions, transient currents were indeed completely abolished and peptide-activated 
currents had a step-like appearance with no strong desensitization (Fig. 19A). Moreover, a 
second peptide application elicited a current of similar amplitude as the first application (for 
EGTA, 96 ± 5 % of the first amplitude, p = 0.7, and for BAPTA, 94 ± 2 % of the first 
amplitude, p < 0.01, paired t test, n = 11, Fig. 19A). In addition to the disappearance of 
transient currents, sustained currents had significantly smaller amplitudes after injection of 
EGTA or BAPTA (for EGTA, 43 ± 6 % of the sustained current amplitude without EGTA 
injection, p < 0.01, and for BAPTA, 47 ± 6% of the sustained current amplitude without 
BAPTA injection, p < 0.01, n = 11; Fig. 19A), suggesting that the CaCC current may 
contribute not only to the transient but also to the sustained component of the peptide-
activated currents. There were no significant differences in oocytes injected with EGTA or 
BAPTA. Therefore, in the remainder of this study, EGTA was used to prevent a rise in 
intracellular [Ca2+]. 
To further test for the activation of the CaCC, extracellular Ca2+ was replaced by Ba2+, which 
does not activate CaCCs (Barish, 1983). Indeed, in the presence of Ba2+, peptide-activated 
currents had a step-like appearance like after chelation of intracellular Ca2+ (Fig. 19B). 
Furthermore, CaCCs were pharmacologically blocked by 5-nitro-2-(3-phenylpropylamino)-
benzoate (NPPB) (Wu and Hamill, 1992). 100 µM NPPB reduced the amplitude of transient 
currents by about half and of sustained currents by 28% (p < 0.05; n = 8; Fig. 19B), 
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indicating partial block of CaCCs by 100 µM NPPB, which is similar to previous reports (Wu 
and Hamill, 1992; Schroeder et al., 2008).  
To exclude the possibility that NPPB had a direct effect on HyNaC those experiments were 
repeated with EGTA-injected oocytes. The amplitudes of currents in the presence of Ba2+ 
were now ~2-fold increased compared to currents in the presence of Ca2+ (n = 8, p < 0.001), 
suggesting either that Ba2+ potentiated HyNaC currents or that Ca2+ blocked HyNaCs. 
NPPB slightly reduced the amplitude of HyNaC currents from 0.88 ± 0.1 to 0.75 ± 0.09 µA 
(n = 8, p = 0.2, paired t test; Fig. 19C), indicating that NPPB has no strong direct effect on 
HyNaC. 
 
 
Fig. 19: Chelation of Ca2+i abolishes transient peptide-activated currents. (A) Top, representative HyNaC2/3/5 currents in 
oocytes injected with EGTA or BAPTA. Note the absence of a transient current and the step-like appearance of the 
currents. Bottom, bar graphs comparing the peak (hatched bars) and sustained (white bars) current amplitudes of 
oocytes expressing HyNaC and of oocytes expressing HyNaC and injected with EGTA (black bars) or BAPTA (green 
bars) (n = 11). (B) Top, representative current trace comparing peptide-activated currents in standard bath and in 
standard bath, in which CaCl2 was replaced by an equimolar amount (1.8 mM) of BaCl2. Currents were measured either 
in the presence or the absence of 100 µM NPPB. Oocytes were pre-incubated for 20 s in the corresponding test solutions 
prior to activation by 1 µM RFamide I. Bottom, bar graph comparing the current amplitudes in the absence of NPPB 
(white or hatched bars) and in the presence of 100 µM NPPB  (red bars) for the indicated conditions. In the presence of 
Ba2+, no transient current was discernible. The application sequence of the individual solutions was shuffled (n = 8). (C) 
As in (B), for oocytes that had been injected with EGTA. Note the absence of peak currents. Bottom, bar graph 
comparing the current amplitudes in the absence of NPPB (white bars) and in the presence of 100 µM NPPB  (red bars) 
for sustained currents. *, p < 0.05; ***, p < 0.001. 
(Adapted from: Dürrnagel et al., 2012) 
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So far, these results strongly argue for an activation of the endogenous CaCC by HyNaCs. 
Peptide-activated inward currents of HyNaC-expressing oocytes apparently are the sum of 
a Na+ current flowing through HyNaCs and a Cl- current flowing through CaCCs, with 
CaCCs being responsible for the biphasic kinetics of the currents. To directly test this 
interpretation, HyNaCs were activated in the absence of extracellular Na+ (Fig. 20A). 
All Na+ was replaced by the large monovalent cation NMDG+ (but solution still contained 1 
mM Ca2+), which should abolish most of HyNaC inward currents. Under these conditions, 
HydraRFamide I still elicited a current with biphasic kinetics but of smaller amplitude. Peak 
current amplitudes were ~70% (n = 4, p = 0.14) and sustained currents ~30% (n = 4, p < 
0.001) of the currents measured in standard NaCl solution. In control experiments with a 
solution containing NMDG+ nominally free of Ca2+, no inward current was observed (n = 4; 
 
Fig. 20: Peptide-activated currents in the absence of Na+e. (A) Left, representative current trace for HyNaC2/3/5 
in solutions containing 1 mM Ca2+ together with either 140 mM NMDG+ or Na+. 1 µM RFamide I was used for 
activation. Right, control experiment in NMDG+ solution nominally free of Ca2+. Similar results were observed in 
4 out of 4 oocytes. (B) Left, representative current trace for HyNaC2/3/5 in solutions containing 10 mM Ca2+, 10 
mM Ca2+ and 10 mM Na+, or 10 mM Na+ (nominally free of Ca2+). Solutions additionally contained 10 mM 
HEPES (pH 7.4) and NMDG+ at concentrations to reach similar osmolarity (10 Ca2+: 125 mM NMDGCl, 10 
Ca2+/10 Na+: 115 mM NMDGCl, 10 Na+: 130 mM NMDGCl,). Oocytes had been injected with EGTA; 2 µM 
RFamide I was used for activation. Holding potential was -85 mV. Right, quantitative comparison of current 
amplitudes. ***, p < 0.001. 
(From: Dürrnagel et al., 2012) 
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Fig. 20A). These results are consistent with the idea that Ca2+ influx through HyNaCs 
secondarily activated CaCCs, greatly amplifying the HyNaC current.  
To directly show Ca2+ influx through HyNaC, the channel was activated in the presence of 
Ca2+ (10 mM) as the exclusive extracellular cation and in EGTA-injected oocytes to prevent 
activation of the CaCC (Fig. 20B). Under these conditions, HydraRFamide I indeed induced 
a step-like inward current with an amplitude of 0.15 ± 0.01 mA (n = 11; Fig. 20B), directly 
demonstrating robust influx of Ca2+ through HyNaC. Addition of an equimolar concentration 
of Na+ (10 mM) did only slightly increase the current amplitude to 0.16 ± 0.01 mA (n = 11, p 
< 0.01), whereas in the presence of Na+ (10 mM) as the exclusive cation, peptide activated 
currents were increased ~3-fold (0.47 ± 0.04 µA, n = 11, p < 0.001; Fig. 20B). The smaller 
current amplitude with a higher total concentration of permeant cations (10 mM Ca2+/10 mM 
Na+ compared with 10 mM Na+ alone) suggests that Ca2+ blocks HyNaC, in addition to 
permeating it. This behavior as a permeant blocker prohibits a direct quantitative 
comparison of the inward Na+ and Ca2+ currents. 
 
3.2.3 HyNaCs are unselective cation channels.  
In Fig. 15A and in a previous report (Golubovic et al., 2007), an Erev of sustained peptide-
activated currents in HyNaC expressing oocytes of ~10 mV was reported indicative of an 
unselective ion channel. As the Cl- currents through CaCCs contaminate the sustained 
peptide-activated currents, a re-evaluation of Erev of HyNaC was necessary. HyNaCs were 
activated in oocytes for 50 s and stepped the holding potential from -70 mV to +30 mV in 
steps of 10 mV every 5 s. Erev was determined in three different solutions: 1) standard bath, 
2) standard bath with EGTA-injected oocytes, and 3) standard bath, in which Ca2+ had been 
replaced by Ba2+ (Fig. 21). Similar to the results in Fig. 15A and Fig. 18B, in standard bath, 
currents had an Erev of 11.5 ± 2.5 mV (n = 8) and were characterized by strong inward 
rectification. In EGTA-injected oocytes, Erev was shifted to more positive values (24.0 ± 3.7 
mV, n = 6, p < 0.05) and currents were also inwardly rectifying. It should be noted that the 
strong inward rectification in these two conditions rendered the determination of Erev 
imprecise. When Ca2+ was replaced by Ba2+, two things changed: Erev was shifted to 3.0 ± 
1.9 mV (n = 7, p < 0.05) and current-voltage relations became linear. These results show, 
first, that HyNaCs indeed have an Erev indicative of a relatively unselective cation channel 
and, second, that extracellular Ca2+ is the cause of their inward rectification, presumably by 
blocking HyNaCs at more positive voltages. 
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 This Ca2+-block could explain why currents were enhanced when Ca2+ was replaced by 
Ba2+ (Fig. 19C), why transient Cl-- currents were smaller at more depolarized potentials in 
standard bath (Fig. 18B), and why Na+ currents were strongly reduced by an equimolar 
amount of Ca2+ (Fig. 20B). It is concluded that Ca2+ is a permeant blocker of HyNaCs and 
that the block is voltage dependent. Ca2+ strongly blocks HyNaC already at -85 mV (Fig. 
20B), but more strongly as the membrane potential becomes more depolarized, leading to 
an almost complete block of HyNaC at positive potentials (Fig. 21).  
At present, a definite explanation for the shift of Erev when Ca2+ had been replaced by Ba2+ 
(Fig. 21) is missing.  
 
 
Fig. 21: Preventing a rise in [Ca2+]i changes Erev of sustained peptide-activated currents. I/V relations for 
HyNaC2/3/5 activated by 1 µM HydraRFamide I in standard bath (open circles), in standard bath after injection 
of EGTA (filled squares) and in standard bath, in which CaCl2 had been replaced by BaCl2 (filled triangles). 
Currents were normalized to the current measured at -70 mV, which had an amplitude of -4.4 ± 1.1 µA (Ca2+), -
1.4 ± 0.2 µA (Ca2+/EGTA), or -6.0 ± 0.8 µA (Ba2+) (n = 7 - 8), respectively. The inset shows the I/V relations 
close to the reversal potentials on an expanded scale. 
(From Dürrnagel et al., 2012) 
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3.2.3 Ca2+ permeability of HyNaC is high.  
Activation of CaCCs indirectly measures Ca2+ permeation through HyNaC. To directly 
measure Ca2+ permeation, we additionally performed photometric Ca2+ measurements using 
Fura-2 (this experiment was done in collaboration with Björn Falkenburger from the 
Department of Neurology, RWTH Aachen University). Application of HydraRFamide I to 
oocytes that expressed HyNaC and had been injected with Fura-2 led to a robust increase 
(Golubovic et al., 2007) in the F340/F380 ratio, indicating an increase in cytosolic Ca2+ (Fig. 
22A). Simultaneous measurement of currents revealed that the [Ca2+]i increase paralleled 
the opening of the HyNaC pore (Fig. 22A). [Ca2+]i quickly rose after channel opening and 
remained high during channel activation. A similar rise in [Ca2+]i was observed in all oocytes 
tested (n = 8, p < 0.001, paired t test; Fig. 22B). The robust signal in photometric Ca2+ 
measurements after opening of HyNaCs and the robust activation of CaCCs by HyNaC 
suggest a high Ca2+ permeability of HyNaCs. 
To estimate the relative Ca2+ permeability of HyNaC, Erev was determined in two different 
Ca2+ concentrations and with EGTA-injected oocytes. To increase the contribution of the 
 
Fig. 22: Activation of HyNaC increases [Ca2+]i in oocytes. (A) Representative trace (black) from photometric Ca2+ 
measurements illustrating the increase of the F340/380 ratio in a HyNaC2/3/5 expressing oocyte after 
application of RFamide I (asterisk). Oocytes had been injected with 50 nl Fura-2AM (1 mM) 30-120 min prior to 
the recording. Thus, the increased F340/380 ratio reflects an increase in [Ca2+]i. The red trace represents the 
current that paralleled the rise in [Ca2+]i. HyNaC was activated by pipetting HydraRFamide I into the bath to yield 
a final concentration of 1 µM RFamide I. (B) Changes of the F340/F380 ratio due to activation of HyNaC for 
individual measurements (n = 8). 
(From: Dürrnagel et al., 2012) 
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Ca2+ current to the total current, Na+ was replaced by the larger, impermeant cation NMDG+. 
In 1 mM Ca2+, Erev was -43 ± 1.5 mV (n = 9) while in 10 mM Ca2+ it was significantly shifted 
to -17 ± 2.6 mV (n = 10, p < 0.001; Fig. 23A). To assess these values, identical 
measurements were performed with P2X4, a purinergic ion channel of known high Ca2+ 
permeability (PCa/Pmono = 4.2; (Soto et al., 1996). In fact, Erev of P2X4 in 1 mM and 10 mM 
Ca2+ were similar to previously published values for P2X4 (Soto et al., 1996) and to Erev of 
HyNaC (Fig. 23B), suggesting that PCa/Pmono of HyNaC is on the same order as that of 
P2X4.  
Finally, the relative Ca2+ permeability PCa/PNa of HyNaC was calculated by determining the 
shift in Erev when the solution contained either Ca2+ or Na+ as the main permeant cation. As 
mentioned above, Erev with 10 mM Ca2+ was -17 ± 2.6 mV and with 140 mM Na+ it was 
shifted to 14 ± 2.5 mV (n = 8; Fig. 23A), allowing to calculate a permeability ratio PCa/PNa = 
3.85 (n = 8; see Methods 2.3.6), which is in good agreement with PCa/Pmono of P2X4. 
 
 
Fig. 23: Permeability ratio PCa/PNa of HyNaC is comparable to P2X4. (A) I/V relations of HyNaC2/3/5 in solutions 
containing 1 or 10 mM CaCl2 and no NaCl (which had been replaced by 140 or 126.5 mM NMDG-Cl, 
respectively) and in a solution containing 140 mM NaCl and 1 mM CaCl2. Continuous voltage ramps were run 
with a speed of 0.46 ms per mV (thus, for example, 6 s per 130 mV). Different voltage ranges were chosen for 
different conditions. Currents were normalized to Imax. Lines are the sum of 8 - 10 individual measurements. 
S.E.M. is indicated by grey errors bars. 50 nl EGTA (20 mM) was injected prior to the recordings. Squares 
represent the reversal potentials that are plotted in (B). HyNaC was activated by 2 µM RFamide I. (B) Ca2+ 
dependent shifts of the reversal potential reveal a high Ca2+ permeability of HyNaC. Reversal potentials of the 
highly Ca2+-permeable P2X4 receptor are shown for comparison and were similar to HyNaC. P2X4 was 
activated by 10 µM ATP. 
(Adapted from: Dürrnagel et al., 2012) 
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To calculate the permeability ratio PNa/PK (see Methods 2.3.6) of HyNaC, Erev was 
determined in solutions containing 140 mM of either Na+ or K+, yielding a relative 
permeability PNa/PK = 3.0 (n = 8; data not shown), which is in agreement with the results in 
Fig. 15B. The higher relative permeability for Na+ over K+ of HyNaC compared with P2X4 
(PNa/PK ~1; (Soto et al., 1996) can explain the slightly more positive Erev of HyNaC in 10 mM 
Ca2+ (-17 ± 2.6 mV compared with -27 ± 1 mV, p < 0.01) in the experiment shown in Fig. 
23B.  
In summary, these results provide consistent evidence for a high relative Ca2+ permeability 
of HyNaC. 
 
3.2.3 Negative charges at the outer entrance to the ion pore are 
necessary for the high Ca2+-permeability of HyNaC.  
ASIC1a is a DEG/ENaC that is slightly permeable for Ca2+ (Waldmann et al., 1997b; 
Bässler et al., 2001; Samways et al., 2009) and at the same time blocked by Ca2+ (Paukert 
et al., 2008). A ring of conserved aspartates at the outer mouth of the ASIC1a pore is crucial 
for Ca2+ block, presumably by constituting a Ca2+ binding site (Paukert et al., 2008). These 
aspartates are conserved in HyNaC subunits 2, 3 and 5 (Fig. 24A). Therefore it was 
investigated, whether these residues contribute to Ca2+ permeability of HyNaCs. 
Substitution of the conserved aspartate by cysteine in all three HyNaC subunits (2/3/5; see 
Methods 2.2.4) resulted in functional channels (HyNaC_D-C). Activation of HyNaC_D-C in 
oocytes evoked currents similar to HyNaC wt (Fig. 24B), but the presence of a peak current 
component was more variable, suggesting reduced activation of CaCCs by HyNaC_D-C. 
Furthermore, current amplitudes were smaller than for HyNaC wt, as would be expected 
when CaCCs were less efficiently activated. To compensate for the smaller current 
amplitudes, a 20-fold greater amount of cRNA for HyNaC_D-C was injected. When Na+ was 
replaced by NMDG+ (keeping 1 mM Ca2+) to abolish most of HyNaC_D-C inward currents, 
HydraRFamide I no longer elicited robust currents (Fig. 24C), whereas it elicited robust 
inward currents in standard bath (I = 1 ± 0.25 µA, n = 5; Fig. 24C).  
As shown above, the currents in the absence of Na+ are CaCC currents. These findings 
indicate that activation of HyNaC_D-C does not efficiently activate CaCCs and supports 
reduced Ca2+ influx through HyNaC_D-C. In standard bath, Erev of HyNaC_D-C was +16 ± 2 
mV (n = 6; Fig. 24D), indicative of a relatively unselective cation current, similar to HyNaC 
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wt. Of note, HyNaC_D-C currents were not inwardly rectifying (Fig. 24D), showing that the 
conserved Asp is necessary for inward rectification and in line with the requirement of Ca2+ 
for inward rectification. In EGTA-injected oocytes, HyNaC_D-C currents in the presence of 
10 mM Ca2+ as the sole extracellular cation were tiny and ~7-fold smaller than in the 
presence of 10 mM Na+ (0.01 ± 0.004 µA compared with 0.07 ± 0.01 µA, n = 11; Fig. 24E); 
the addition of Ca2+ (10 mM) to the Na+ containing solution only slightly decreased the 
current amplitude by 29 ± 3 % (0.05 ± 0.01 µA, n = 11, p < 0.001; Fig. 24E), whereas for 
HyNaC wt, it decreased the current amplitude by 74 ± 2% (p < 0.001; Fig. 20B). These 
results are consistent with the interpretation that HyNaC_D-C had a lower Ca2+ permeability 
and was less blocked by Ca2+ than HyNaC wt.  
 
 
Fig. 24: A conserved aspartate is necessary for the high Ca2+ permeability of HyNaC. (A) Alignment of the amino 
acid sequences of HyNaC2, 3, and 5 and ASIC1a at the beginning of the second transmembrane domain TMD2 
in the one-letter code. The crucial aspartate is indicated by an asterisk. Completely conserved amino acids are 
shown as white letters on black background. (B) Representative current trace for HyNaC_D-C activated by 1 µM 
RFamide I. The amplitude and shape of the transient current component was more variable than for the wt. 
Mean maximum current amplitudes were 3.45 ± 1.2 µA for the first activation (n = 5). (C) Representative current 
trace showing activation of HyNaC_D-C by 1 µM RFamide I in solutions containing 1 mM Ca2+ together with 
either 140 mM NMDG+ or Na+. No inward current was visible in NMDG+ solutions. (D) I/V plot for HyNaC_D-C 
activated by 1 µM RFamide I in standard bath solution. Currents were normalized to the current measured at -70 
mV, which had an amplitude of -1.1 ± 0.2 µA (n = 6). (E) Left, representative current trace for HyNaC_D-C in 
solutions containing 10 mM Ca2+, 10 mM Ca2+ and 10 mM Na+, or 10 mM Na+ (nominally free of Ca2+). 
Conditions were as in Fig. 3B. Right, quantitative comparison of current amplitudes. ***, p < 0.001. 
(Adapted from: Dürrnagel et al., 2012) 
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With 1 and 10 mM Ca2+ in EGTA-injected oocytes, Erev of HyNaC_D-C was significantly 
shifted to more negative potentials compared with HyNaC wt (n = 7 - 8, p < 0.001; Fig. 25A 
and Fig. 25B), confirming a reduced Ca2+ permeability of HyNaC_D-C. 
 
 
 
Fig. 25: A conserved aspartate is necessary for the high Ca2+ permeability of HyNaC. (A) I/V relations of HyNaC_D-C 
in solutions containing 1 or 10 mM CaCl2 and no NaCl (which had been replaced by 140 or 126.5 mM NMDG-Cl, 
respectively) and in a solution containing 140 mM NaCl and 1 mM CaCl2. Lines are the sum of 8 - 9 individual 
measurements. S.E.M. is indicated by grey errors bars. Experimental conditions were as in Fig. 23A. Triangles 
represent the reversal potentials that are plotted in (B). (B) Ca2+ dependent shifts of the reversal potential reveal a 
significantly lower Ca2+ permeability of HyNaC_D-C compared with HyNaC wt. Reversal potentials of HyNaC wt and 
P2X4 (grey symbols) are from Fig. 23B and shown for comparison. (C) Representative trace (black) from 
photometric Ca2+ measurements illustrating no change of the F340/380 ratio after application of RFamide I (1 µM; 
asterisk) in a oocyte expressing HyNaC_D-C. The deflections in the F340/380 ratio immediately after the peptide 
was added are due to movements of the solution and unspecific. Oocytes had been injected with 50 nl Fura-2AM (1 
mM) 30-120 min prior to the recording. The red trace represents the current that robustly increased after peptide 
application. (D) F340/F380 before and after application of 1 µM RFamide I for HyNaC_D-C (n = 8). (E) Plot of the 
increase of the F340/380 ratio (in %) after application of RFamide I as a function of peptide-activated current 
amplitudes. Filled squares represent individual measurements for HyNaC wt and open triangles for HyNaC_D-C (n = 
8). Current amplitudes were smaller for HyNaC_D-C than for HyNaC wt (n = 8, p < 0.001; Fig. 22B). Solid lines 
represent linear fits of the fluorescence/current ratio. Note that the slope of this line was larger for wt than for the D-C 
mutant, indicating a higher relative Ca2+ permeability of the wt. 
(Adapted from: Dürrnagel et al., 2012) 
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The relative Ca2+ permeability of HyNaC_D-C, calculated by determining the shift in Erev 
when the solution contained either Ca2+ or Na+ as the main permeant cation (Fig. 25A; see 
Methods 2.3.6), was PCa/PNa = 0.44 (n = 8), thus 9-fold smaller than for HyNaC wt. In 
contrast, the permeability ratio for monovalent cations was comparable to HyNaC wt  
(PNa/PK = 2.9, n = 8; data not shown). These results suggest that the inefficient activation of 
CaCCs by HyNaC_D-C is caused by its strongly reduced Ca2+ permeability.  
In photometric Ca2+ measurements, activation of HyNaC_D-C did not significantly increase 
the F340/F380 ratio (n = 8, p = 0.12, paired t test, Fig. 25D; example in Fig. 25C), 
consistent with a reduced Ca2+ influx in HyNaC_D-C expressing oocytes. As expected, the 
increase in F340/F380 ratio correlated with the current amplitude and could be fitted 
reasonably well with a line (Fig. 25E). This linear regression analysis for F340/F380 ratio 
change versus current showed a shallower slope for the D-C mutant than for HyNaC wt (p < 
0.01; Fig. 25E), which is also consistent with a reduced Ca2+ permeability of HyNaC_D-C.  
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IV. Discussion 
4.1 Part I: HyNaC2/3/5 forms a high affinity peptide 
receptor 
4.1.3 HyNaC2/3/5 shows typical features of DEG/ENaC channels 
The first part of this work describes the cloning and functional characterisation of HyNaC5, 
a novel DEG/ENaC subunit from Hydra. It is shown that the HydraRFamide I induced 
current amplitudes of HyNaC2/3 are potentiated ≈16-fold when HyNaC5 is coexpressed 
together with HyNaC2 and -3 (Fig. 13A). This finding, together with other results discussed 
below, strongly suggests that HyNaC2/3/5 forms a heteromeric peptide-gated ion channel. 
The identification of three homologous HyNaC subunits that together form a functional 
DEG/ENaC channel is similar to ENaC which is also composed of three (α,β,γ) subunits 
(Canessa et al., 1994). Reminiscent of the situation in HyNaCs, two ENaC subunits (αβ or 
αγ) are sufficient for generating small, constitutive currents and these currents are 
potentiated ≈25 to 50-fold by coexpression of the γ subunit (Canessa et al., 1994). In ENaC, 
the small currents reported for the αβ or αγ subunits can be attributed to a poor 
incorporation of these subunits into the membrane and coinjection of the γ subunit 
enhances surface expression ≈20-fold (Firsov et al., 1996). In contrast to this, surface 
expression of the tagged HyNaC2-HA/3 channel was not altered by coinjection of HyNaC5 
(Fig. 13C). In the case of HyNaC2/3/5, the larger current amplitudes most likely depend on 
an increased single channel amplitude or an increased open channel probability. We 
speculate that the HydraRFamides I and II are partial ligands for HyNaC2/3 i.e. they open 
the channel pore less effectively than the HyNaC2/3/5 pore which could explain the reduced 
whole cell currents. 
The finding that three HyNaCs subunits concertedly form a high affinity receptor is also 
compatible with the crystal structure of ASIC1a, which revealed an homotrimeric assembly 
of this channel (Baconguis and Gouaux, 2012). As HyNaCs are closely related to ASICs, it 
is reasonable to assume that HyNaCs are also composed of three subunits. In the case of 
HyNaC2/3/5, this directly implicates a 1:1:1 ratio for the subunits in the functional channel 
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complex. Collectively, the findings suggest that a trimeric structure is an evolutionary 
conserved feature of all DEG/ENaCs. 
Similar to HyNaC2/3, HyNaC2/3/5 is activated by the HydraRFamides I and II. Compared to 
HyNaC2/3, the apparent affinity for HyNaC2/3/5 is ≈100-fold increased and EC50 values for 
the HydraRFamides I and II were ≈5 µM and ≈0.35 µM, respectively (Fig. 14). For FaNaCs, 
the closely related peptide-gated ion channels, apparent affinities ranging from ≈2 µM for 
HaFaNaC (Lingueglia et al., 1995) to ≈70 µM for HtFaNaC (Jeziorski et al., 2000) were 
reported. Therefore, HyNaC2/3/5 has the highest apparent affinity of all known peptide-
gated ion channels.  
In the first part of this work, the permeability of HyNaCs for Ca2+ had not been noticed. The 
influx of Ca2+ through HyNaCs activates CaCCs, which are endogenously expressed in 
Xenopus oocytes (Miledi, 1982; Barish, 1983; Schroeder et al., 2008). Therefore, all current 
traces shown in this part are the sum of two individual currents. A HyNaC current, carried by 
Na+ and Ca2+ and an additional Cl- current due to secondary activation of CaCCs. Without 
block of contaminating Cl- currents, the indicated EC50 values for the HydraRFamides I and 
II and the comparison of current amplitudes between HyNaC2/3 and 2/3/5 may be 
imprecise. However, as CaCCs are activated by HyNaCs, one might assume that the 
fraction of the CaCC current is roughly proportional to the HyNaC current. Indeed, 
concentration-response curves with oocytes that had been injected with EGTA to block 
contaminating CaCCs, yielded comparable EC50 values for HyNaC2/3/5 (Marc Assmann, 
personal communication). Fig. 19A shows that the CaCC current fraction of the total current 
in HyNaC2/3/5 injected oocytes is ≈4 times higher than the HyNaC2/3/5 current fraction. 
The CaCC current contributing to the total current for HyNaC2/3 injected oocytes was not 
determined but is likely in the same range. This implicates that the ≈16-fold increased 
current amplitude of HyNaC2/3/5 compared to HyNaC2/3 (Fig. 13A) is due to a larger 
charge flux through HyNaC2/3/5 and cannot be explained by an increased activation of 
CaCCs. However, an exact quantification of current amplitudes and apparent peptide 
affinities of HyNaC2/3 and HyNaC2/3/5 would demand additional measurements with EGTA 
injected oocytes. 
HyNaC2/3 is equally permeable for Na+, Li+ and K+ which is an unusual feature for a 
DEG/ENaC channel (Golubovic et al., 2007). In contrast to this, in an ion exchange assay 
HyNaC2/3/5 showed significantly higher currents in solutions containing Na+ as main 
charge carrier than in K+ containing solutions directly indicating an increased selectivity for 
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Na+ (Fig. 15B). Controversially, the reversal potentials in standard bath Na+ solution were 
not altered between both channels (Fig. 15A). One possible explanation for this is that the 
reversal potentials are affected by activation of CaCCs as they were measured without 
injection of EGTA. Assuming an intracellular Cl- concentration of 33 mM (Barish, 1983) the 
calculated equilibrium potential of Cl- in the used solution is ≈ -38 mV. This would cause a 
leftward shift of reversal potentials and the impact would depend on the magnitude of CaCC 
activation by HyNaCs. This could explain why the increased Na+/K+ current ratio of 
HyNaC2/3/5 measured in the ion exchange assay did not manifest in the voltage ramps. 
The reversal potentials of HyNaC2/3/5 under different ionic conditions were therefore re-
evaluated in the second part of this work with a different experimental protocol and CaCCs 
were blocked by injection of EGTA (Fig. 21). In addition, the PNa/PK ratio was also 
determined in a new experiment with blocked CaCCs and yielded a PNa/PK value of ≈3 (see 
3.2.3), which is in good agreement with the results obtained in the ion exchange assay 
confirming the slight selectivity of HyNaC2/3/5 for Na+. 
Similar to the selectivity for Na+, the sensitivity for the inhibitor amiloride is a common 
feature of DEG/ENaCs (Kellenberger and Schild, 2002). Therefore, the relatively low 
apparent sensitivity of HyNaC2/3 for amiloride (IC50 ≈ 500 µM) (Fig. 16; see also (Golubovic 
et al., 2007) is exceptional. In contrast, HyNaC2/3/5 was shown to be ≈ 5-fold more 
sensitive for amiloride (Fig. 16). Similarly, the sensitivity for benzamil and phenamil is also 
enhanced. The sensitivity for amiloride did not depend on the applied HydraRFamide 
concentration, suggesting that both substances do not compete for the same binding site. 
Collectively, these findings implicate that sensitivity for amiloride is an evolutionary 
conserved feature of DEG/ENaCs. Since amiloride has been shown to act by blocking the 
open channel pore in other DEG/ENaCs (Brown et al., 2007), it is reasonable to assume a 
similar mechanism in HyNaCs. This would suggest the basic pore properties of 
DEG/ENaCs manifested itself early in evolution. 
In summary, the following results suggest that HyNaC5 is incorporated into the HyNaC2/3 
channel complex:  
• The apparent affinity for both HydraRFamides increases ≈100-fold. 
• The peptide-induced currents are potentiated ≈16-fold. 
•  The sensitivity for amiloride is ≈5-times increased. 
•  HyNaC2/3/5 is more Na+ selective.  
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In addition, the selectivity for Na+ and the increased sensitivity for amiloride strongly 
resemble other DEG/ENaC channels. It is therefore suggested that the channel complex 
containing HyNaC2/3/5 is more likely the physiologically relevant channel in Hydra than the 
complex formed byHyNaC2/3 only.  
 
4.1.3 Physiological implications of HyNaCs 
To investigate the physiological function of HyNaCs, we investigated the feeding reaction in 
Hydra. Interestingly, the GSH-induced feeding response, which includes movement of the 
tentacles, was significantly delayed when the animals were bathed in 100 µM amiloride (Fig. 
17). Moreover, the coordinated movement of the tentacles towards the hypostome was also 
impaired. The effect was reversible and did not affect general behaviour of the animals. 
Therefore, one might speculate that HyNaCs play an important role in generating the 
feeding reaction of Hydra. However, it is important to mention that an unspecific effect of 
amiloride cannot be excluded.  
Consistent with the observed effect of amiloride in the feeding reaction, the whole mount in 
situ hybridization revealed the expression of hynac2, -3, -4 and -5 at the bases of the 
tentacles in adult animals, most likely in the epitheliomuscular cells (Fig. 11). Therefore, the 
specific expression of hynac2-4 corresponds with a putative role of HyNaCs in generating 
coordinated movement of the tentacles during the feeding reaction. Subtle differences in the 
expression of hynac4 and hynac5 were observed in adult animals (Fig. 12). hynac5 is 
predominantly expressed at the oral site of the tentacles, whereas hynac4 expression is 
restricted to the aboral site. One might speculate that channels containing HyNaC5 or 
HyNaC4 have different physiological functions e.g. in regulating contraction or extension of 
the tentacles during feeding behaviour. In Xenopus oocytes, HyNaC4 did not show any 
currents after application of the HydraRFamides I-IV when HyNaC4 was expressed either 
alone or in combination with HyNaC2 and 3 (Golubovic et al., 2007). Only for HyNaC2/4/5 
small currents were observed that were ≈10% of the size of the HyNaC2/3 (Fig 11A). 
Therefore, one might speculate that HyNaC4 associates with hitherto undiscovered subunits 
and forms an ion channel with different properties compared to the channel made of 
HyNaC2/3/5. Indeed, a BLAST search revealed that the genome of Hydra magnipapillata 
contains at least seven further genes related to the known HyNaCs indicating that more 
HyNaCs exist that may be gated by the HydraRFamidees III and VI.  
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The expression pattern of hynac1-4 at the base of the tentacles and the expression of 
hynac2, -3, and -5 during budding overlaps with the previously reported expression of the 
preprohormones A-C (Fig. 26). These preprohormones are precursor peptides that are 
cleaved to give rise to HydraRFamides (Hansen et al., 2000 Table 2). Especially the 
expression pattern of preprohormone A from which the HydraRFamides I-V are derived is 
very similar to the expression of the hynac genes. This strongly suggests that 
HydraRFamides are the natural ligands of HyNaCs in vivo. To date, the ligand binding site 
of the HydraRFamides I and II is not known. However, in a recent study the binding site of 
psalmotoxin, a small peptide toxin that acts as gating modifier of ASIC ion channels was 
identified (Baconguis and Gouaux, 2012). Psalmotoxin was shown to bind ASIC1 in in the 
acidic pocket, a region containing several negative charged residues that is formed by 
intersubunit contacts between the thumb, β-ball and finger domains together with residues 
from the palm domain (Jasti et al., 2007 Fig. 3). Further studies will show, whether the 
homologous region is also the peptide-binding site of HyNaCs. 
 
 
 
Fig. 26: (Left) Whole mount in situ staining with antibodys against the preprohormones A, B, C. (Adapted 
from: Hansen et al. 2000). (Right) In situ staining showing expression pattern of HyNaC5. (Adapted from: 
Dürrnagel et al., 2012) 
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4.2 Part II: HyNaC2/3/5 is highly permeable for Ca2+ 
4.2.3 Several lines of evidence document the high Ca2+ 
permeability of HyNaC2/3/5  
The first part this thesis describes the characterisation of HyNaC5, a novel DEG/ENaC 
subunit from Hydra. In the first part of this thesis and in a previous paper dealing with the 
characterisation of HyNaC2/3 (Golubovic et al., 2007), the biphasic currents after 
application of HydraRFamides were entirely attributed to currents flowing through the 
HyNaC pore. The results in the second part of this work now show that those previous 
conclusions were wrong. HyNaCs are highly Ca2+-permeable members of the DEG/ENaC 
gene family. In Xenopus oocytes, this high Ca2+-permeability leads to robust activation of 
the endogenous CaCC, and the Cl- current adds to the cation current flowing through 
HyNaC itself. This secondary activation of the CaCC is entirely responsible for the biphasic 
appearance of peptide-activated currents in HyNaC expressing oocytes. This conclusion is 
based on several different observations. 1) Erev of the transient current is Cl- dependent; 2) 
intracellular chelation of Ca2+ abolishes the transient current and leads to step-like HyNaC 
currents; 3) HydraRFamides elicit biphasic inward currents also in the absence of permeant 
monovalent cations; 4) Ca2+ measurements reveal an increase in [Ca2+]i that parallels the 
opening of the HyNaC pore; and 5) Erev of HyNaC is Ca2+ dependent. These results 
consistently show that HyNaCs are Ca2+-permeable. Moreover, it is shown that HyNaC 
currents have no strong time dependence; in the presence of the intracellular Ca2+ chelators 
EGTA or BAPTA, HydraRFamides elicit step-like currents that do not desensitize. The 
apparent biphasic HyNaC current and tachyphylaxis from first to second peptide application 
arise from the secondary activation of the CaCC. Consequently, tachyphylaxis was 
abolished in cells injected with EGTA (Fig. 19). 
Several ligand-gated channels share a high Ca2+ permeability with HyNaCs and activate 
CaCCs when expressed in Xenopus oocytes, among them NMDA receptors (Leonard and 
Kelso, 1990), kainate receptor GluR6 (Egebjerg and Heinemann, 1993), α7 and α9 nicotinic 
acetylcholine receptors (Galzi et al., 1992; Vernino et al., 1992; Séguéla et al., 1993; Katz et 
al., 2000), and purinergic P2X4 receptors (Soto et al., 1996). The estimate of the Ca2+ 
permeability of HyNaCs, PCa/PNa = 3.85, revealed a Ca2+ permeability similar to that of P2X4 
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(Soto et al., 1996), PCa/Pmono = 4.2, placing HyNaCs among the highly Ca2+ permeable 
ligand-gated ion channels. It should be mentioned, however, that PCa/PNa ratios obtained by 
measurements of the shift in reversal potentials generally have to be regarded with caution 
as the GHK constant field voltage equation, which was used to calculate permeability ratios, 
requires that there is no interaction among permeating ions (Burnashev et al., 1995; Hille, 
2001). Like for most ion channels, this is not the case for HyNaCs, implying that PCa/PNa is 
not constant but depends in a complex manner on the voltage and the individual 
concentrations of divalent and monovalent ions on both sides of the membrane. For 
example, for HyNaC a ratio PCa/PNa ≈ 10 was estimated, when using Erev in a solution 
containing 1 mM (instead of 10 mM) Ca2+ (Fig. 23A). 
The FMRFamide-activated Na+ channel, FaNaC, is another peptide-gated ion channel from 
the DEG/ENaC gene family (Lingueglia et al., 1995). When expressed in oocytes, 
FMRFamide elicits currents that develop comparatively slowly over a few seconds and that 
partially desensitize (Fig. 5). Moreover, FaNaC shows a reversal potential indicative of a 
highly Na+ selective ion channel (Lingueglia et al., 1995). Thus, kinetics and ion selectivity 
are considerably different between the only two known peptide-gated ion channels, both 
from the DEG/ENaC gene family.  
 
4.2.3 A conserved Asp confers high Ca2+-permeability 
In addition, the second part of this work identifies a conserved aspartate, necessary for the 
high Ca2+ permeability of HyNaCs. Again, this finding is based on several observations. 1) 
When the conserved aspartate was substituted by a cysteine (HyNaC_D-C), Hydra-
RFamides elicit no strong inward currents in the absence of permeant monovalent cations; 
2) Erev with Ca2+ as main charge carrier was significantly shifted compared to wt; 3) the 
relative Ca2+ permeability was reduced to PCa/PNa = 0.44; and 4) photometric Ca2+ 
measurements revealed no increase in [Ca2+]i when channels opened. The aspartate is 
conserved in ASICs and is crucial for Ca2+ block of ASICs (Paukert et al., 2008) and for 
coordinating monovalent cations at the outer ASIC pore (Gonzales et al., 2009). Thus, likely 
these aspartates form a ring of negative charges at the outer entry of the HyNaC pore that 
attracts cations, in particular Ca2+. Removing the aspartate abolished inward rectification 
(Fig. 24D), suggesting that the aspartate is a determinant of a Ca2+ binding site, which 
mediates Ca2+ block and thus inward rectification of HyNaC.  
Since ASICs also have the crucial Asp but are impermeable for Ca2+, with the exception of 
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ASIC1a that has a low Ca2+ permeability (Bässler et al., 2001; Samways et al., 2009), the 
Asp is necessary but not sufficient for Ca2+ permeability of HyNaCs. Reminiscent of this 
situation, for NMDA receptor channels it has been proposed that Ca2+ interacts with 
“external” and “deep” sites, corresponding to regions at the external mouth and central in 
the pore of the channel, respectively (Watanabe et al., 2002). The conserved aspartate of 
HyNaCs and ASICs could represent an external Ca2+ interaction site and the putative 
internal site would also be necessary for Ca2+ permeation. In fact, for ASIC1, amino acids at 
the intracellular N-terminus determine Ca2+ permeability (Bässler et al., 2001). Future 
experiments will show whether the high Ca2+ permeability of HyNaCs also depends on their 
intracellular N-termini or other regions along the axis of their pore.  
Collectively, the results suggest the following scenario (Fig. 27): Ca2+ gets attracted to the 
outer mouth of the HyNaC pore by the negative charges of the conserved ring of aspartates. 
At positives potentials (for example, +30 mV), Ca2+ inefficiently permeates the channel and 
blocks the open pore, presumably by tightly binding to the aspartates. At more negative 
potentials (for example, -70 mV) Ca2+ more efficiently permeates the channel, liberating the 
pore for the passage also of monovalent cations. 
Recently, the crystal structure of ASIC1 in complex with psalmotoxin revealed two different 
open channel conformations depending on the pH at which the crystals were derived 
(Baconguis and Gouaux, 2012). At acidic pH (5.5) the ASIC pore is selective for sodium. In 
this state, the pore has an asymmetric, elliptical structure with its narrowest constriction of 
≈5-7 Å at about halfway of the membrane (Fig. 4B). In contrast to this, at neutral pH (7.25) 
the pore is unselective for monovalent cations and also permeable for the large NMDG+ that 
has a radius of ≈4 Å. If the pore is also conductive for Ca2+ was not tested. In the 
unselective state (neutral pH), the ion pore has a threefold symmetric shape and is lined by 
the TM1 and TM2 helices of the three subunits (Fig. 4B). It would be interesting to 
investigate, if the unselective HyNaC pore has a similar structure as the ASIC1 pore at 
neutral pH.  
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4.2.3 HyNaCs are the first DEG/ENaC channels with a high Ca2+ 
permeability 
So far, all DEG/ENaC channels have been found to be more or less Na+ selective; in fact, 
Na+ selectivity is a defining hallmark of these channels. In the few exceptions, where 
DEG/ENaC channels are associated with unselective ion pores, the unselective state co-
exists with a Na+-selective state, as in the case of some ASICs (Lingueglia et al., 1997; 
Springauf and Gründer, 2010) and rat brain liver intestine Na+ channel (rBLINaC, now 
named bile acid-sensitive ion channel, BASIC) (Sakai et al., 1999; Wiemuth and Gründer, 
2010; Wiemuth et al., 2012). In these cases, the Na+ selective state probably carries most 
of the current under physiological conditions. MEC-4, a subunit of a mechanosensitive 
DEG/ENaC channel from C. elegans (Driscoll and Chalfie, 1991), can be constitutively 
activated by mutation (MEC-4(d)) and then carries a Ca2+ component with a permeability 
ratio of Ca2+ versus Na+ (PCa/PNa) of 0.22 (Bianchi et al., 2004), > 10-times lower than for 
 
Fig. 27: In the closed conformation (left), Ca2+ can probably access the extracellular vestibule through three 
lateral fenestrations and bind to the conserved aspartates at the outer mouth of the ion pore. After binding of the 
ligand, HyNaC opens and, at negative membrane potentials, Ca2+ permeates the channel (–70 mV, middle), 
liberating the ion pore. At depolarized potentials (+30 mV, right), however, Ca2+ remains bound to the ring of 
negative charges and blocks the open pore. Based on the crystal structure of chicken ASIC1 (Jasti et al., 2007)  
(From: Dürrnagel et al.,2012) 
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HyNaCs. Moreover, the physiologically relevant current carried by MEC-4 is a Na+-current 
(Goodman et al., 2002; O'Hagan et al., 2005). Thus, HyNaCs are the first DEG/ENaC 
channels that are unselective cation channels with a high Ca2+ permeability.   
At present, one can only speculate on the role of Ca2+ permeability for the physiological 
function of HyNaCs. HyNaCs are expressed at the base of the tentacles, perhaps in 
epitheliomuscular cells (Fig. 11), and the preprohormone gene that encodes their ligands 
Hydra-RFamides I and II, is expressed in adjacent nerve cells of the hypostome and upper 
gastric region (Hansen et al., 2000). Therefore, one can speculate that HyNaCs contribute 
to coordinate the Hydra feeding response. In agreement with this hypothesis, Antho-
RFamide (pQGRF-NH2), a related RFamide peptide from anthozoans, another class within 
the phylum Cnidaria that contains sea anemones, has excitatory actions on sea anemone 
muscle preparations and increases the frequency of spontaneous tentacle contractions 
(McFarlane et al., 1991). Thus, the action of Antho-RFamide is compatible with the idea that 
HydraRFamides are transmitters at neuromuscular junctions and that HyNaCs are their 
postsynaptic receptors. Of note, another anthozoan neuropeptide, Antho-RWamide I 
(pQSLRW-NH2), increases an inward Ca2+ current in endodermal myoepithelial cells of sea 
anemones (Cho and McFarlane, 1996). Whatever the exact physiological function of 
HyNaCs is, it is likely that Ca2+ influx through open HyNaCs supports their function. The 
block by Ca2+ of HyNaC will limit influx of Ca2+, especially at more depolarized membrane 
potentials. 
In summary, the results show that HyNaC has simple kinetics and does not desensitize in 
the prolonged presence of its ligands and that HyNaC is an unselective cation channel with 
a high Ca2+ permeability, which is an uncommon feature of DEG/ENaC channels. Therefore, 
it is possible that the highly selective Na+ pore of DEG/ENaC channels that is a 
characterizing feature of these channels is in fact a feature that was not shared by the 
common ancestor and arose later in evolution. 
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VI. Appendix 
6.1  List of experimental procedures performed by other 
researchers 
The experimental protocols listed below were performed by other researches. Prof. Stefan 
Gründer performed cloning of HyNaC5. The in situ hybridization and the analysis of the 
feeding behaviour of Hydra were done in collaboration with the lab of Prof. Thomas 
Holstein, at the Institute of Zoology, Heidelberg. Anne Kuhn did the in situ hybridisation 
staining; the analysis of feeding behaviour was performed by Dr. Charisos Tsiairis. 
 
6.1.3 Cloning of HyNaC5 
Several partial sequences for a protein showing sequence homology to HyNaCs were 
identified from the on-line Hydra expressed sequence tag data base and used to design 
primers for rapid amplification of 3´-cDNA ends (RACE). Using the Smart RACE cDNA 
amplification kit (Clontech), two rounds of 3-RACE were performed with cDNA prepared 
from poly(A)+ RNA, isolated from adult one-day starved budding stage Hydra magnipapillata 
(strain 105). Full-length HyNaC5 was assembled from expressed sequence tags and 3-
RACE products. For expression studies in Xenopus oocytes, the entire coding sequence of 
HyNaC5 was amplified by PCR from cDNA of whole Hydras and subcloned. The clone was 
entirely sequenced to exclude PCR errors. The consensus sequence of HyNaC5 was 
assembled from the expressed sequence tags and several independent PCR products. This 
sequence data has been submitted to the DDBJ/EMBL/GenBankTM databases under 
accession number FN257513. 
 
6.1.2 In Situ Hybridization of Hydra 
 A1435-bp fragment from the coding part of HyNaC5 cDNA was subcloned in the vector 
pBluescript KS. Whole mount ISH was carried out as described previously (Martinez et al., 
1997) by using BMP Purple as substrate for the antibody-conjugated alkaline phosphatase, 
except that blocking of the animals was performed in monoclonal antibody/1x blocking 
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reagent (Roche Applied Science) and that the alkaline phosphatase-conjugated anti-
digoxygenin Fab fragments (Roche Applied Science) were diluted 1:4000. Two different 
antisense probes of 810 and 1435 bp, respectively, were used at concentrations of 0.08–
0.16 ng/µl for 60 h. Both probes applied alone or together resulted in the same localization 
pattern, a combination of both probes yielding a stronger signal than the single probes. 
Performing ISH with the corresponding sense riboprobes did not display any staining. 
 
6.1.3 Analysis of the Feeding Reaction of Hydra 
Five animals of the species H. magnipapillata (wild-type strain 105) were placed in 10 ml of 
Hydra medium (1.0 mM Tris-HCl, 1.0 mM NaHCO3, 0.1 mM KCl, 0.1 mM MgCl2, and 1.0 
mM CaCl2) or Hydra medium supplemented with 100 µM amiloride. Once they were relaxed 
in the new medium, glutathione was added to a final concentration of 10 µM at time 0. Every 
30 s, we recorded the number of animals moving their tentacles as a response to the 
application of glutathione. The experiments were repeated four times. Additional 
experiments were performed with Hydra oligactis without finding any differences (data not 
shown).
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List of abbrevations 
°C degree celsius 
5-HT serotonine 
A ampere 
Å angström 
ACH acetylcholine 
AMPA 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid 
approx. approximal 
Arg arginin 
Asp aspartate 
ATP adenosine triphosphate 
Ba2+ barium 
BAPTA 1,2-bis(o-aminophenoxy)etahne- N,N,N',N'-tetraacetic acid 
BASIC bile acid sensing ion channel 
BLINaC brain-liver-intestine sodium channel 
bp baise pair 
BSA bovine serum albumin 
C- carboxy 
Ca2+ calcium ion 
CACC calcium-activated chloride channel 
cDNA complement DNA 
cfu colony forming unit 
Cl- chloride 
CNS central nervous system 
Cs caesium 
Da dalton 
DEG degenerin 
DEPC diethylpyrocarbonate 
DNA deoxyribonucleic acid 
E epinephrine 
e.g. lat.: exempli gratia 
EC50 ligand concentration evoking 50% of the maximal activation 
ECD extracellular domain 
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EDTA ethylenediaminetetraacetic acid 
EGTA ethylene glycol tetraacetic acid 
ENaC epithelial sodium channel 
EPSP excitatory postsynaptic potential 
Erev reversal potential 
EtOH ethanol 
FaNaC FMRFamide-gated sodium channel 
fig. figure 
FLR fluoride resistant mutant 
FMRFamide phenylalanine-methionine-arginine-phenylalanine-amide 
g  gram 
g  standard gravity 
GABA gamma-aminobutyric acid 
GluR glutamate receptor 
GPCR G-protein coupled receptor 
GSH gluthatione 
h hour 
H+ proton 
HA hemaglutinine 
HaFaNaC FaNaC from Helix aspersa 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HG-motif histidine-glycine-motif 
His histidine 
HtFaNaC FaNaC from Heliosoma trivolis 
HyNaC Hydra sodium channel 
Hz herz 
I electric current  
i.e. lat. : id est 
IC50 inhibitor concentration evoking 50% of the maximal inhibition 
IgG immunoglobuline G 
Imax maximal electric current 
INaC human intestine sodium channel 
ISH in situ hybridisation 
k kilo 
List of abbrevations 
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K+ potassium ion 
kB kilobase 
l litre 
lat. Latin 
Li+ lithium ion 
M molar 
MCS multiple cloning site 
MEC mechanosensitive mutants 
Met methionine 
mg milligram 
Mg2+ magnesium ion 
ml milliliter 
mmol millimol 
mRNA messenger ribonucleic acid 
mV millivolt 
MΩ megaohm 
n count of samples 
N- amino 
NA numerical apperture 
Na+ sodium ion 
NaAc sodium actetate 
Nae extracellular sodium 
NaGluc sodium gluconate 
NE norepinephrine 
ng nanogram 
NH2 amide 
nl nanolitre 
nm nanometer 
NMDA N-Methyl-D-aspartic acid 
NMDG N-methyl-D-glucamine 
nmol nanomol 
NO nitric oxide 
NPFF neuropetide FF 
NPPB 5-nitro-2-(3-phenylpropylamino)-benzoate 
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NPSF neuropeptide SF 
OR-2 oocyte-ringer solution 2 
p probability 
p pyro 
PCR polymerase chain reaction 
Phe phenylalanine 
pmol picomole 
PPK pickpocket 
Pro proline 
PVP polyvinylpyrrolidone 
RACE rapid amplification of 5´and 3´-cDNA ends 
RLU relative light units 
RPK ripped pocket 
rpm rotations per minute 
s second 
S.D. standard deviation 
S.E. standard error 
S.E.M. standard error of the mean  
Tab. table 
TEA tris acetate EDTA buffer 
TEVC two electrode voltage clamp 
Tm melting temperature 
TM transmembrane domain 
TRP transient receptor potential channel 
Trp tryptophan 
Tyr thyrosine 
U enzyme unit 
UV ultraviolett light 
v/v volume/volume 
Vhold holding potential 
Vm membrane potential 
w/w weight/weight 
wt wildtype 
µ: micro
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